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Abstract
To better understand the role of cholinergic signaling in specific regions of the brain, several
genetically modified mice targeting the vesicular acetylcholine transporter (VAChT) gene
have been generated (Prado et al., 2006; Guzman et al., 2011; de Castro et al., 2009). VAChT
stores acetylcholine (ACh) in synaptic vesicles, and changes in this transporter expression
directly interferes with ACh release. Here, we use a mouse line with VAChT deletion in the
pedunculopontine tegmental nucleus (PPT) to evaluate the consequences of decreased
cholinergic signaling from the PPT in vivo. Based on the efferent connectivity from the PPT,
our hypothesis is that decreased cholinergic signaling from the PPT will affect specific
behavioural outputs. It was determined that these mice have strong deficits in spatial and
goal-directed learning as well as an antidepressive-like phenotype. Mild phenotypes include
gait abnormalities, anxiety-like behavior and decreased compulsivity. Improving our
understanding of cholinergic signaling from the PPT and how it relates to behavioural
abnormalities may lead to the development of novel treatments for the symptoms of
neurological diseases such as PD and PSP, which show degeneration of PPT neurons (Hirsch
et al. 1987).
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Chapter 1

1

The Cholinergic System
Acetylcholine (ACh) was the first neurotransmitter to be discovered. This

neurotransmitter, described by Otto Loewi in 1921 (Mesulam et al., 1984), is one of the
major neurotransmitters in the central nervous system (CNS), and it is also the main
neurotransmitter in the peripheral nervous system (PNS) In the CNS, there are two
primary sources of acetylcholine: local interneurons or projection neurons that innervate
distal targets. Tonically active cholinergic interneurons are located mainly in the dorsal
striatum and the nucleus accumbens (reviewed by Picciotto et al., 2012). Projection
neurons originate mainly from two brain regions: the pedunculopontine nucleus and
lateral dorsal tegmentum nuclei (together known as the mesopontine tegmentum) located
in the brainstem (Mesulam et al., 1995), and also from the basal forebrain (Zaborszky et
al., 2008). Mesulam and colleagues (1984) utilized immunohistochemistry to divide all
the cholinergic neurons into six major categories based on their connectivity patterns in
the rat and primate brain. The Ch1 and Ch2 groups of neurons provide the major
cholinergic input to the hippocampus. The Ch3 group project to the olfactory bulb and
the Ch4 group of cholinergic neurons topographically innervate the entire neocortical
mantle. The Ch5 and Ch6 groups are the major source of cholinergic innervation of the
thalamus. Each of the Ch categories are also delineated by distinct nuclear boundaries
(Mesulam et al., 1984).
ACh can act as a neuromodulator in the CNS by changing the state of neurons so
their response to subsequent stimulation is altered (Picciotto et al., 2012). The actions of
ACh are mediated through receptors on a large number of neuronal subtypes, both preand post-synaptically. These receptors fall into two classes: metabotropic acetylcholine
receptors (mAChRs) and ionotropic nicotinic acetylcholine receptors (nAChRs)
(reviewed by Picciotto et al., 2000; Wess 1996).
There are five unique subtypes of the mAChR receptor (M1-M5), all of which are
G-protein-coupled receptors (Wess 1996). mAChR are linked to either Gq or Gi/o type G-
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proteins. The M1, M3 and M5 receptors are linked to the Gq protein, whereas the M2 and
M4 receptors are coupled to Gi/o type G-proteins (Wess 1996). The Gq proteins activate
phospholipase C, while Gi/o proteins negatively couple to adenylate cyclase (Wess 1996).
The nAChRs are non-selective cation channels with a molecular mass of 290 kDA
that cause depolarization of the neuron (Changeux et al., 1998; Picciotto et al., 2001).
These allosteric receptors respond to ACh and nicotinic agonists by quickly (μs to ms
range) opening the channel that is permeable to Na+, K+ and sometimes Ca2+ ions
(Changeux and Edelstein, 2005). nAChRs are transmembrane oligomers made up of five
subunits symmetrically arranged around a central ionic channel. The combinations of
subunits have distinct expression patterns in specific neuronal types (Gotti et al., 2007).
The nAChR subunits, encoded by 12 genes, have been classified into two subfamilies of
proteins: nine α-subunits (α2-α10) and three β–subunits (β2-β4) (Gotti et al., 2007). The
nAChRs can also be classified based on their pharmacological properties into groups of
receptors that are sensitive to α-Bungarotoxin (homomeric and heteromeric receptors
consisting of α7, α8, α7-8, α9 and/or α10 subunits) and receptors that are insensitive to αBungarotoxin (heteromeric receptors consisting of α2-α6 and β2-β4 subunits) (Gotti and
Clementi, 2004). The various nAChRs subunit combinations differ in their cellular
localization in the brain. There are two main types of nAChRs in the brain: the α7 homooligomer and the α4β2 hetero-oligomer (Changeux and Edelstein, 2005). The α7 nAChR
is characterized by fast activation and desensitization, a low affinity for ACh and a high
Ca2+ permeability (Gotti et al., 2007) and it is located presynaptically (Jones and
Wonnacott, 2004). The α4β2 nAChR is characterized by a low desensitization, a high
affinity for ACh and nicotinic agents, and it is strongly upregulated by nicotine exposure
(Changeux and Edelstein, 2005, Picciotto et al., 2001; Reviewed by Buisson and
Bertrand, 2002). β2-containing nAChRs and α7 nAChRs are widely expressed in the
brain (Gotti et al., 2007) whereas other subtypes have a more restricted expression.
Interestingly, chronic exposure of nAChRs to ACh or nicotinic agonists results in a
gradual decrease in the rate of response to the ligand and ultimately a high-affinity,
desensitized, closed state of the receptor (Changeux and Edelstein, 2005).
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1.1 Acetylcholine
To synthesize ACh, the precursor choline must be brought into the cell by the highaffinity choline transporter (CHT1) or SLC5A7 (solute carrier family 5 member 7)
(reviewed by Ribeiro et al., 2006). Once in the cytoplasm of nerve terminals, choline is
used to synthesize ACh by the enzyme choline acetyltransferase (ChAT) (Prado et al.,
2002; Parsons 2000). The vesicular ACh transporter (VAChT) or SLC18A3 (solute
carrier family 18 member 3) loads ACh into synaptic vesicles (Prado et al., 2002; Parsons
2000). Thousands of molecules of ACh are packaged into a synaptic vesicle to form a
quantum so ACh can be released by exocytosis.

1.2 The High-Affinity Choline Transporter
In the CNS, cholinergic neurons are incapable of synthesizing ACh de novo, so their
ability to signal with this neurotransmitter depends on the neurons ability to uptake
choline (Tucek 1985). To do this, neurons have two carrier-mediated transport systems
for choline uptakewhich are located in the pre-synaptic nerve terminal (Haga 1971). The
concentrations of available choline in the extracellular space determines which system is
used for choline transport. At high concentrations, choline is transported into the neuron
by a low-affinity system that is Na+-independent, whereas at low concentrations, the
high-affinity Na+-dependent system predominates. The high-affinity transporter is
distinguished from the low-affinity transporter by its inactivation by hemicholinium-3 as
well as its dependence on extracellular Na+ and Cl- levels (Yamamura and Snyder, 1972).
Okuda and Haga (2000) were the first to isolate the cDNA encoding CHT1 in the rat
brain. CHT1 is unique to cholinergic neurons because choline is specifically converted
into ACh only when the high-affinity transporter is used, whereas choline taken up with
the low-affinity transporter is not converted to ACh (Yamamura and Snyder, 1972).
Choline uptake is believed to be the rate-limiting step in ACh synthesis (Okuda and
Haga, 2000). In order to maintain ACh synthesis, CHT1 is used to recover choline from
the synapse after ACh hydrolysis by AChE (Birks and MacIntosh, 1961). While CHT1
function is predominantly at the plasma membrane, it has been demonstrated that this
protein is located on the plasma membrane, as expected, but also on presynaptic vesicles
that were positive for VAChT (Ribeiro et al., 2003; Ferguson et al., 2003).
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Depolarization leads to an increase in the Vmax for high-affinity choline uptake as well as
an increase in the density of CHT proteins in the plasma membrane (Ribeiro et al., 2003;
Ferguson et al., 2003). These results suggest that large intracellular stores of CHT1 are
available to be delivered to the plasma membrane when the rate of ACh release is
increased.

1.3 The Enzyme Choline Acetyltransferase
ChAT is a single-stranded globular protein that mediates the transfer of an aceyl
group from acetyl coenzyme A (acetyl-CoA) to choline at the synaptic terminals of
cholinergic neurons to generate ACh (Oda 1999). The enzyme is synthesized in the
perikaryon of cholinergic neurons and is transported to the nerve terminal through
axoplasmic flow (Oda 1999). There, it can exist in two forms: a soluble form (80-90% of
total enzyme activity) and an insoluble membrane-bound form (10-20% of total enzyme
activity). Smith and Carroll (1993) demonstrated that in the rat hippocampal tissue,
ChAT can be fractionated with synaptic vesicles, suggesting that a portion of the
membrane-bound ChAT may be attached to cholinergic synaptic vesicles by a glycosylphosphatidylinositol anchor.
Genomic studies by Misawa et al. (1992) have identified a number of ChAT mRNA
species that are transcribed from different promoter regions and produced by differential
splicing. Interestingly, the genomic structure of ChAT is unique in addition to being
complex: the VAChT gene is embedded in the first intron of the ChAT gene (Erickson et
al., 1994), which was subsequently named the “cholinergic gene locus” (Erickson et al.,
1994; Eiden 1998). Inside the first intron there is a 1590 bp open reading frame (ORF)
that encodes the VAChT protein, which is in the same transcriptional orientation as the
ChAT gene (Bejanin et al., 1994). Alternative splicing of this single precursor mRNA
gives rise to two proteins involved in sequential biochemical steps: synthesis and storage
of ACh (Alfonso et al., 1994). Several studies have confirmed the coexpression of the
ChAT and VAChT proteins. Benjanin et al. (1994) investigated whether signals (such as
retinoic acid) that induced ChAT gene expression also induced VAChT gene expression,
and found that the agents increased the mRNA and protein levels of both products,
indicating a common regulatory mechanism of their transcription.
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In Drosophila, VAChT and ChAT transcripts contain the same complete first exon
and use a common promoter upstream of the ChAT first exon (Kitamoto et al., 1998).
However, in vertebrates, the expression mechanisms are far more complicated. There are
several different promoters in the 5’ region of the cholinergic gene locus: a common
promoter for R-type ChAT and VAChT mRNA (upstream of ChAT exon R), two
promoters for VAChT mRNA between ChAT exon R and the VAChT ORF, and one
promoter for M-type ChAT mRNA between ChAT exons N and M (Mallet et al., 1998).
The different ChAT mRNA transcripts are summarized in Figure 1.
ChAT&
exon&R&

P

VAChT&
exon&&

P P

ChAT&
exon&N&

ChAT&
exon&M&

ChAT&
exon&#4&

P
R1&
R2&
N1&

ChAT%
mRNA%

N2&
M&

Figure 1. The vertebrate cholinergic gene locus and the five ChAT mRNA
transcripts produced by differential splicing. P = promoter. Adapted from Mallet et
al. 1998.

The primary structure for ChAT reveals a number of putative phosphorylation sites
and short-term post-translational regulation of the ChAT enzyme by protein kinases has
been demonstrated. For instance, Dobransky et al. (2001) demonstrated that
phosphorylation of serine 440 by protein kinase C (PKC) increased enzyme activity, and
may also alter subcellular localization (Dobransky et al., 2001). It is likely that
phosphorylation influences whether the protein will be soluble or membrane-bound and
as well as the enzyme’s catalytic activity, which in turn alters the biosynthesis of ACh
(Cooke and Rylett, 1997).
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1.4 The Vesicular Acetylcholine Transporter
VAChT is also critical to the functioning of the cholinergic system as it is required
for ACh storage. The importance of VAChT is emphasized by VAChT knockout mice
that cannot survive after birth due to respiratory dysfunction and atrophied skeletal
muscle (de Castro et al., 2009). The consequences of reduced VAChT expression have
been demonstrated using genetically modified mice with a knockdown of VAChT gene
expression. The homozygous VAChT knockdown mice (VAChT-KDHOM) have a 62%
decrease in VAChT protein levels and present severe muscular fatigue and cognitive
alterations. However, heterozygous VAChT knockdown mice (VAChT-KDHET) have a
40% decrease in VAChT expression but they survive into adulthood with no muscular
dysfunction but similar cognitive changes to those seen in the VAChT-KDHOM mice
(Prado et al., 2006).
VAChT is a 12-transmembrane domain protein with a 75 kDa molecular mass that is
part of the Major Facilitator Superfamily of transporters (Alfonso et al., 1994; Erikson et
al., 1994; Vardy et al., 2004). The exact three-dimensional structure of VAChT is not
known, but a model has been proposed based on the structure of two other members of
this family: lactose permease and glycerol 3-phosphate (Vardy et al., 2004). The 12
transmembrane helices are suggested to form two bundles, one composed of helices I-IV
and the other composed of helices VII-XII (Khare et al., 2010), with both the N- and Cterminus regions projecting into the cytoplasm. It is helix X that contains Trp331 and
Asp398 which are the amino acids involved in ACh binding and proton translocation,
respectively (Fritz et al., 2001; Kim et al., 1999). VAChT has been localized to the
perinuclear region in the cell bodies of ChAT-positive neurons, as well as to the nerve
terminals (Roghani et al., 1998). Of the two types of secretory vesicles in the cholinergic
nerve terminal (synaptic vesicles and large-dense core vesicles, LDCVs), immunogold
studies indicate that VAChT is found in the synaptic vesicle population (Gilmore et al.,
1996). The C-terminal of VAChT contains a di-leucine motif required for clathrinmediated endocytosis, and this is the site of regulation for its trafficking within the
neuron (Varoqui and Erickson 1998; Barbosa J Jr et al., 2002; Ferreira et al., 2005). The
amino acid sequence of the C-terminal tail of VAChT reveals a consensus
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phosphorylation site for PKC, suggesting that post-translational modification of VAChT
could change ACh storage, and subsequently release (Erickson et al., 1994, Roghani et
al., 1994). Specifically, Krantz et al. (2000) identified serine 480 as the major
phosphorylation site in the protein and PKC as the kinase involved. Krantz et al. (2000)
also demonstrated in stable transfected PC12 cells that a S480E mutation increases
VAChT expression in LDCVs by diverting VAChT trafficking away from endosomes.
VAChT utilizes the electrochemical gradient created by V-type proton ATPase
(Parsons 2000) to bring ACh into the synaptic vesicle by exchanging two luminal protons
for a cytoplasmic ACh molecule (Nguyen et al., 1998). The impermeability of the
secretory vesicles provides a large proton-motive force that drives the accumulation of
ACh inside the vesicle so that the vesicular ACh concentration is 100-fold greater than
the cytoplasmic concentration (Eiden 1998). However, the electrochemical potential
created by the ATPase is sufficient to concentrate ACh 3000-fold greater in synaptic
vesicles than in the cytoplasm, suggesting that there are regulatory mechanisms that
arrest the vesicular ACh filling (Parsons 2000). Varoqui and Erickson (1996)
demonstrated that VAChT is a very slow transporter, and that in PC12 cells that
overexpress human VAChT, the transport of [3H]ACh is saturable, suggesting that
VAChT is likely the rate-limiting step for ACh release from the nerve terminal. The
level of expression of VAChT thus has a great influence on the release of this
neurotransmitter. Song and colleagues (1997) over-expressed VAChT in xenopus
neurons and found that it increased the amount of ACh released by the synaptic vesicles.
As well, they found that the neuron had an increase in the number of miniature EPSPs,
which suggests that more synaptic vesicles were becoming competent to store and release
ACh than usual (Song et al. 1997). Synaptic vesicles themselves do not regulate the
amount of ACh stored within them, but the level of VAChT expression on the vesicle
dictates the amount of neurotransmitter released (Prado et al., 2002).

1.5 ACh-Glutamate Co-transmission
Recent studies have shown that some cholinergic neurons in the brain express a
vesicular glutamate transporter (VGluT) in addition to VAChT, and thus have the
potential to release both ACh and glutamate. For example, cholinergic neurons in the
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striatum co-express VGluT3 (Schafer et al., 2002; Gras et al., 2008; Guzman et al.,
2011). Basal forebrain cholinergic neurons projecting to the amygdala also co-express
VGluT3 (Nickerson et al., 2006). While the mechanisms of regulation of VAChT are
unknown, it has been shown that ACh loading into the synaptic vesicles can be
influenced by the VGluT3 activity through a process called vesicular synergy (Gras et al.,
2008). It has been suggested by Hnasko and collegues (2012) that accumulating the
negatively charged glutamate inside these cholinergic neurons changes the pH value to
increase VAChT transport activity.
In a number of studies, animal models of cholinergic deficiency have generated
by using electrolytic or excitotoxic methods, as well as cholinergic immunolesion, to
ablate cholinergic neurons (Schliebs and Arendt, 2006). These studies often destroy noncholinergic neuron in addition to the cholinergic neurons, or they do not fully deplete the
cholinergic neurons. More importantly, lesions destroy neurons that may be co-releasing
glutamate and ACh, which prevents researchers from distinguishing the behavioural
effects of these two neurotransmitters. The use of genetically modified mice with VAChT
knockouts restricted to a unique brain region provides a means to elucidate the role of
cholinergic deficiency specifically (Guzman et al., 2011; Martyn et al., 2012; Kolisnyk et
al., 2013).
The comparison of striatal VGluT3-KO mice with striatal VAChT-KO mice
(VAChTD2-Cre-flox/flox mice) highlights the effect of ACh/glutamate co-transmission, and
also the importance of separating the physiological role of each of these neurotransmitters
(Guzman et al., 2011). For instance, mice with a lesion of cholinergic neurons in the
striatum have been found to be hyperactive and more responsive to cocaine than controls
(Hikida et al., 2001; Kitabatake et al., 2003), so this phenotype was initially attributed to
the loss of cholinergic signaling from striatal interneurons. Two genetically modified
mouse lines were created to differentiate the behaviours controlled by the glutamateric
and cholinergic neurotransmission. VGluT3-KO mice did not have glutamate release
from the striatal cholinergic interneurons, and behavioural analysis of these VGluT3-KO
mice revealed that they are also hyperactive and more responsive to cocaine than controls
(Gras et al., 2008). The VAChTD2-Cre-flox/flox mice do not release acetylcholine from

9

striatal cholinergic interneurons but the behavioural analysis of these mice revealed that
they are not hyperactive and they do not have altered cocaine-induced behaviour
(Guzman et al., 2011). This comparison suggests that it was the glutamate release from
the cholinergic neurons, not the ACh release that was responsible for the phenotype
observed in the lesion studies.

2

Pedunculopontine Tegmental Nucleus
Integrity of the proteins involved in ACh synthesis, storage and release, functioning

muscarinic and nicotinic receptors and intact neurons are all critical for the functioning of
the cholinergic system. Dysfunction of the cholinergic system has been implicated in a
number of diseases, such as Alzheimer’s disease (Prado et al., 2013). The potential role
of altered cholinergic signaling in neurobiological disease has brought the
pedunculopontine nucleus (PPN, in humans) or pedunculopontine tegmentum (PPT, in
rodents) into the scientific spotlight. Significant loss of cholinergic neurons of the PPT
has been demonstrated in post-mortem studies of patients with Parkinson’s disease (PD)
and progressive supranuclear palsy (PSP), a Parkinson’s-like syndrome (Jellinger 1988,
Warren et al., 2005). It has been shown that 40-50% of PPN cholinergic neurons
degenerate in Parkinson’s patients and over 60% degenerate in patients with PSP
(Jellinger 1988). Understanding the behaviours regulated by this cholinergic nucleus is
fundamental in determining how degeneration in this area leads to the symptoms
observed in PD and PSP patients.

2.1 PPT Anatomy
The PPT is composed of a highly heterogeneous population of neurons that differ by
their connectivity, behaviours they regulate, and their discharge properties (MartinezGonzalez 2012). The three major neuron types in the PPT are cholinergic, GABAergic
and glutamatergic (Martinez-Gonzalez 2012). Not only are the types of neurons and their
function heterogeneous, but so is the distribution of these neuronal subtypes across the
PPT. The pedunculopontine tegmental nucleus has two subdivisions based on the cell
density and distribution of the Ch-5-group cholinergic neurons: the pars compacta (PPTc)
and pars dissipates (PPTd) (Papahill et al., 2000). However, these two subdivisions may
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best be considered anatomically as a two-component structure, with each component
being responsible for distinct behavioural and psychological functions (Winn 2006).
Immunolabeling has identified a rostro-caudal distribution of ChAT-labeled
cholinergic neurons, with more of these neurons in the caudal portion of the PPT
(Martinez-Gonzalez 2012). GABAergic neurons are more concentrated in the rostral
PPT and glutamatergic neurons are more concentrated in the caudal PPT (MartinezGonzalez 2012). The rostro-caudal distribution of the different neuronal subtypes is
highlighted by the changes in cytoarchitecture and organization of the cholinergic
neurons along this axis (Martinez-Gonzalez et al., 2011). Where there is low GABAergic
neuron density (caudal PPT) the cholinergic neurons are bipolar-shaped and organized in
a layer like structure; where GABAergic neuron density is high, the cholinergic neurons
are round-shaped and in a random distribution (Martinez-Gonzalez et al., 2011). The
unique distribution of each neuron subtype is related to the distinct connectivity of the
rostral and caudal portions of the PPT, which suggests that the two regions might be
functionally distinct. Neurochemically, the rostral and caudal sections of the PPT each
have distinct and diverging projections that innervate distant structures (MartinezGonzalez et al., 2011).
In addition to the two shapes of the cholinergic neurons in the PPT, they have also
been shown to have two types of firing patterns: slow-firing and fast-firing (MartinezGonzalez et al., 2011). Mena-Segovia et al. (2008) demonstrated that the slow-firing
neurons correlate to the cortical upstate during slow oscillations and the fast-firing
neurons correlate to the cortical downstate during slow oscillations.
Understanding the different roles each neuronal subtype of the PPT plays in
regulating behaviour is further complicated by the fact immunohistochemistry studies
revealed that 40% of cholinergic neurons in this region also show glutamate
immunoreactivity (Lavoie and Parent, 1994), suggesting that these neurons can co-release
acetylcholine and glutamate. Immunolabeling studies also suggest that some cholinergic
neurons of the PPT coexpress GABA markers as well (Wang and Morales, 2009).
However, when mRNA transcripts of ChAT and glutamic acid decarboxylase (GAD;
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required for production of GABA) were evaluated using in situ hybridization, they found
that only 2% of PPT cholinergic neurons expressed GAD mRNA (Wang and Morales,
2009).

2.2 PPT Connectivity
2.2.1

Efferent Connectivity
A fundamental characteristic of the PPT is the long axons of the cholinergic

neurons that project to very distant structures and have as many as five or six collaterals
(Mena-Segovia et al. 2008).
Numerous tracer experiments have shown that the PPT projects to unique regions
within the basal ganglia system. The subthalamic nucleus (STN) receives cholinergic,
GABAergic and glutamatergic input from the caudal PPT in the monkey (Lavoie and
Parent, 1994; Bevan and Bolam, 1995; Martinez-Gonzalez et al. 2009). The internal
globus pallidus (GPi) in monkeys receives projections from the rostral PPT, of which
40% of the neurons are cholinergic (Woolf and Butcher, 1986; Edley and Graybiel,
1983). The external globus pallidus (GPe) receives only a small input from the PPT
(Charara and Parent, 1994). The dopaminergic neurons of the substantia nigra (SN)
receive input from the rostral PPT, specifically the pars compacta region (SNc) (Futami
et al., 1995; Charara et al., 1996). In monkeys, 25% of these neurons are cholinergic
(Lavoie and Parent, 1994). The ventral tegmental area receives significant cholinergic
input from the caudal PPT in primates (Charara et al., 1996). The thalamus is one of the
primary output centres of the PPT and it is heavily innervated by cholinergic neurons
from the caudal PPT in the monkey (Parent et al., 1988, Takakusaki et al., 1996).
Additionally, the striatum also receives direct projections from the PPT (Nakano et al.,
1990; Dautan et al., 2014).
Until recently, it was believed that cholinergic interneurons were the only source
of ACh in the striatum, and that the PPN only influenced the striatum indirectly through
one of two routes: (1) innervation of midbrain dopaminergic neurons (Bolam et al., 1991)
leading to increased dopamine release onto the striatum (Blaha and Winn, 1993) and (2)
through innervation of the intralaminar and midline thalamus (Mena-Segovia et al., 2008)
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which then project to the striatum (Erro et al., 1999). However, Dautan et al. (2014) used
a Cre-driven mouse line to express the fluorescent protein YFP in cholinergic neurons
(immunolabeled for ChAT) to reveal direct cholinergic innervation of both the dorsal
striatum and nucleus accumbens from the PPT and LDT. These authors showed that the
rostral PPT innervates the dorsolateral striatum, and the caudal PPT innervates the
dorsomedial striatum and nucleus accumbens. Additionally, electron microscopy analysis
of cholinergic synapses revealed that the 74% of synapses from rostral PPN contacted
dendritic shafts, suggesting they contact striatal interneurons, and 26% made contact with
the medium spiny neurons.
Additional areas that have been shown to receive cholinergic inervation from the
PPT are: the inferior and superior colliculi which receive fibers from the caudal PPT
(Mena-Sogovia et al., 2008); the basal forebrain (specifically the magnocellular preoptic
area and the nucleus basalis magnocellualris) which also receives input from the caudal
PPT (Semba et al., 1988; Losier and Semba, 1993; Mena-Segovia et al., 2008); the
posterior lateral hypothalamus (Ford et al., 1995) as well as lower brainstem, pons,
medulla and spinal cord (Martinez-Gonzalez et al., 2009) (Martinez-Gonzalez et al.,
2009). PPT projections to the spinal cord that are thought to be directly involved in
locomotion are primarily non-cholinergic (Skinner et al., 1990). Several studies have also
shown that there is collateralization of targets by the same PPT neurons. For instance,
Takakusakai et al. (1996) demonstrated that one individual cholinergic neuron will
project to the SN, thalamus as well as caudal regions in the brainstem. The efferent
connections from the PPT are summarized in Figure 2.
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Figure 2. Summary of efferent connections of the PPT. GPe = external globus
pallidus, GPi = internal globus pallidus, VP = ventral pallidus, SNc = substania
nigra pars compacta, SNr = substantia nigra pars reticulate, VTA = ventral
tegmental area, rPPT = rostral pedunculopontine tegmental nucleus, cPPT = caudal
pedunculopontine tegmental nucleus, SC = superior colliculus, IC = inferior
colliculus.

2.2.2

PPT Afferent Connectivity
There is not as detailed information regarding the afferent innervation of the PPT,

but it is known that there are direct afferents from the cerebral cortex, thalamus,
hypothalamus, pons, cerebellum, medulla, spinal cord and basal ganglia (Saper and
Loewy, 1982; Semba and Fibiger, 1992).
In monkeys, the prefrontal and frontal lobe areas of the cerebral cortex that are
involved in motor control have direct excitatory projections to the PPT (Matsumura et al.,
2000; Martinez-Gonzalez et al., 2011). As well, tracer studies in primates have shown the
basal ganglia system sends direct projections to the PPT. The STN directly targets
neurons in the PPT with an excitatory input (Nauta and Cole, 1978; Martinez-Gonzalez
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2011) and also indirectly though the SN (Florio et al., 2007). Additionally, the SN pars
reticulata (SNr) has direct projections to the rostral PPT (Nakamura et al., 1989; Semba
and Fibiger, 1992; Spann and Grofova, 1991). The enteropeduncular nucleus (rodents) or
GPi (humans) sends GABAergic projections to the rostral PPT (Morizumi and Hattori,
1992). The ventral striatum was shown to project GABA-releasing neurons to the PPT in
monkeys (Haber et al., 1990).
The PPT receives afferents from deep cerebellar nuclei (Hazarati and Parent,
1992) and receives fast sensory input from superior colliculi in the rat tectum (Woolf and
Butcher, 1986; Semba and Fibiger, 1992). In tracer studies of the rat brainstem, it has
been shown that the dorsal raphe neurons innervate the caudal PPT providing a
serotonergic input (Steininger et al., 1992). The PPT also receives input from the
laterodorsal tegmental nucleus (LDTg) and the contralateral PPT (Semba and Fibiger,
1992).
As a result of these connections, the PPT receives both sensory and motor inputs,
as summarized in Figure 3.
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Figure 3. Summary of afferent connections to the PPT. GPe = external globus
pallidus, GPi = internal globus pallidus, VP = ventral pallidus, SNc = substania
nigra pars compacta, STN = subthalamic nucleus, SNr = substantia nigra pars
reticulate, VTA = ventral tegmental area, DR = dorsal raphe, rPPT = rostral
pedunculopontine tegmental nucleus, cPPT = caudal pedunculopontine tegmental
nucleus, LDT = laterodorsal tegmentum.

2.3 PPT Function
The PPT, with its widespread-projecting neurons and heterogeneous neuronal
subpopulations, is thought to have a complex role in a number of signaling networks in
the brain. Many studies have investigated the possible functional role of the PPT, and to
date, this nucleus is thought to be involved in locomotion and gait, REM sleep/brain state
transitions, and cognitive functions such as attention and reward learning (Winn et al.,
2011).
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2.3.1

Locomotion and Gait
Strong reciprocal connections have been shown between the PPT and structures

involved in the control of motor performance such as the basal ganglia; specifically, the
STN, the SN and the GP (Bolam et al., 1991; Winn et al., 1997; Kita and Kita, 2011).
Recent studies with retrograde and anterograde tracing have identified neuronal circuitry
that is likely to be responsible for the control of locomotion, posture and muscle tone.
Rolland et al. (2011) proposed that the SNr-PPT-reticulospinal circuit could control
posture and axial muscle tone, and the GPi-PPT-reticulospinal circuit could control gait
and locomotion (Rolland et al., 2011). Hikosaka et al. (2000) expanded on the role of the
basal ganglia in the control of movements by suggesting that the basal ganglia has two
kinds of outputs: the thalamocortical network to control volitional movement, and the
outputs to the PPT to control autonomic movements such as saccades and locomotion.
Literature confirming the role of the PPT in locomotion is mixed, however. While
the PPT is considered to be part of the mesencephalic locomotor region, bilateral
excitotoxic lesions of the whole PPT failed to show any effects on locomotion (Inglis et
al., 1994) while bilateral lesions of just the anterior PPT causes a reduction of locomotion
in rats (Alderson et al., 2008). Takakusaki (2008) suggested that the PPT is required for
the initiation and maintenance of motion, and in primates, lesioning the PPT with high
frequency stimulation causes akinesia (Nandi et al., 2002).
Neuropathalogical studies have shown that in humans, 40%-60% of the
cholinergic neurons in the PPT degenerated in PD and PSP patients, respectively
(Jellinger 1988; Bohnen and Albin, 2011). This degeneration of PPT cholinergic neurons
results in cortical and thalamic cholinergic denervation, which is related to gait and
balance issues in these individuals with PD (Bohnen et al., 2009). The AChE inhibitor
donepezil reduced the number of falls in patients with PD by 50% (Chung et al., 2010).
Interestingly, in a rat model of PD (created with 6-hydroxydopamine lesions of the
medial forebrain), analysis of firing patterns of neurons in the basal ganglia system and
PPT following lesion revealed that the resulting increased oscillatory activity in the STN
and SNr is transmitted to the PPT as inhibitory oscillatory output (Aravamuthan et al.,
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2008). These results emphasize the relationship between the PPT, basal ganglia and
motor disturbances in PD.

2.3.2

Cognitive functioning
In addition to the locomotor and gait abnormalities observed in individuals with

PD or PSP, the loss of cholinergic PPT neurons in both diseases is also thought to play a
role in the attentive and cognitive impairments seen in patients (Scarnati and Florio,
1997).

2.3.2.1

Arousal and Attention

Electroencephalography (EEG) has been used to monitor the electrical activity in
the cortex, and there is a pattern of electrical potentials corresponding to an arousal state
(McCormick 1989). For instance, during slow-wave sleep there is a synchrony of cortical
activity, but during wakefulness and alertness there is a desynchronization of the
electrical activity (McCormick 1989). It is known that the thalamus mediates these brain
state transitions by coordinating the neuronal changes from a slow firing rate to phasic
burst firing (Mena-Segovia et al., 2008). The connection between the intralaminar
thalamic nuclei and the PPT has been associated with arousal and attention (Steriade et
al., 1988). Electrical stimulation of the PPT results in this desynchronized EEG, which
supports the role of the PPN in thalamocortical process like arousal (McCormick 1989).
Kobayashi and Isa (2002) found that increased excitability of thalamic neurons increases
visual acuity by decreasing the signal-to-noise ratio of the incoming sensory information.
Behaviourally, this increases alertness and awareness of sensory information from the
environment.
The interaction between the PPT and the thalamus is also thought to influence
attention. Attention involves the ability to detect sensory stimuli, maintain readiness to
respond to stimuli (sustained attention), discriminate significant from insignificant
stimulus (selective attention) and to select and perform the appropriate motor response
(executive control) (Inglis et al., 2000). The 5-choice serial reaction time task (5CSRTT)
is frequently used to evaluate attentional processes in rodents.

In the 5-CSRTT

paradigm, animals are required to detect brief flashes of light presented pseudorandomly
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in one of five locations on a screen and to make a nose-poke response in the correct
spatial location in order to receive a food reward (Bari et al., 2008). The accuracy of the
animal’s response to the light stimulis provides an index of attentional capacity (Bari et
al., 2008). Inglis et al. (2000) lesioned the PPT in mice and evaluated the resulting affects
on attention using this task. Mice with bilateral PPT lesions showed decreased

accuracy and a very high percentage of trials on which no response was made
(omissions) when attentional demands of the task were increased by decreasing the
stimulus duration. These results suggest that the mice are not vigilant to the stimuli,
which emphasizes the importance of the integrity of PPT signaling in attentional
processes.

2.3.2.2

Working memory

The PPT-thalamus circuit has been suggested to be involved in working memory.
Cholinergic innervation to the anteroventral thalamic nucleus (ATN) were shown to be
responsible for spatial- and context-dependent memory (Mitchell et al., 2002).
Additionally, lesions of the ATN in rats led to significant spatial memory deficits in the
radial maze (Sziklas and Petrides 1999). The ATN receives one of the highest numbers of
cholinergic terminals in all of the thalamus from the PPT (Van Groen and Wyss, 1993),
supporting the inclusion of PPT cholinergic signaling in the regulation of spatial memory.

2.3.2.3

Reinforcement learning

Stimulus-response and action-outcome associations are thought to be mediated by
the basal ganglia, specifically due to the input from tonically active neurons in the
striatum that respond to salient sensory events during behavioural conditioning (Schulz
and Reynolds, 2012). These tonically-active neurons (TANs) are cholinergic interneurons
that exhibit a tonic spike discharge (Schulz et al., 2011). Lapper and Bolam (1992)
showed that most of the excitatory inputs to the TANs come from the intralaminar nuclei
of the thalamus, which drives the spiking of the TANs. Electrical stimulation of the
thalamus evoked the spiking of the striatal TANs (Schulz et al., 2011). Schulz and
Reynolds (2013) proposed that regulation of TANs signaling is due to a glutamatergic
input from the thalamus that is triggered by a an early sensory structure, such as the SC or
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the PPT, to ensure that the dopamine burst is uninhibited and delivers a strong
reinforcement signal for the event. In response to salient stimuli, and also to cues that
predict magnitude of reward outcome, PPT neurons become phasically active (Pan and
Hyland, 2005) (Okada et al., 2009), so it is been suggested that PPT outputs, or its
projections to the SC, could be modulating thalamic control of striatal interneurons.
Condé et al. (1992) proposed a learning process model involving the PPT input to
the midbrain dopaminergic neurons as a carrier of reinforcement information. Stimulation
of the PPT results in excitation of the dopaminergic neurons of the SNc and the VTA
(Lacey et al., 1990), which is essential for burst firing in dopaminergic neurons.
Acetycholine acts on nicotinic receptors to depolarize the dopaminergic neurons and alter
their firing rate (Calbresi et al., 1989; Lacey et al., 1990). Rats with lesions in the
posterior PPT (pPPT) have been shown to perform worse than those with anterior PPT
lesions (aPPT) or sham lesion mice in a level-release paradigm, as they were slower to
learn the association between the lever release and the reward (Wilson et al., 2009),
suggesting the PPT-ventral striatal circuitry connection is key for reward-reinforcement
learning. Lesions of the PPT also blocked the reward effects of morphine, amphetamine
or food as measured in the conditioned place preference test (Olmstead and Franklin
1993, 1994). Studies suggest that the PPT is involved in the process of forming as well as
strengthening or maintaining rewarded behaviours through the regulation of dopaminereleasing neurons in the SNc and the VTA (Allen and Winn, 1995).
Recent research using a saccade task in monkeys has also focused on the interplay
between the PPT-Dorsal raphe-Basal ganglia systems and their combined effect on
reinforcement learning (Okada et al., 2011). These studies suggest that the PPT neurons
may be involved in reward prediction. They proposed that the reward prediction
information from the PPT and the actual information about the value of the reward from
the dorsal raphe are integrated to evaluate the errors in reward prediction and signal to
midbrain dopaminergic neurons to reinforce the learned behaviours that elicit the reward,
as summarized in Figure 4.
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Figure 4. Summary of PPT-Dorsal raphe-Basal ganglia reinforcement learning
circuitry. Nac = nucleus accumbens, GPe = external globus pallidus, GPi = internal
globus pallidus, VP = ventral pallidus, SNc = substania nigra pars compacta, SNr =
substantia nigra pars reticulate, VTA = ventral tegmental area, PPT =
pedunculopontine tegmental nucleus, Ser = serotonin, DA = dopamine. Adapted
from Okada et al., 2011.

2.3.3

Sleep
The PPT is thought to be part of the reticular activating system that drives global

brain-state transitions (Ros et al., 2010). This link between cortical brain state and the
PPT is supported by studies that show increases in firing rate of cholinergic neurons
during spontaneous and sensory-induced brain state transitions from slow-wave activity
to activated brain states (fast-frequency, low amplitude; typical of wakefulness, arousal
or REM sleep (Mena-Segovia et al., 2008).
It has been postulated for many years that the PPT is involved in the control of
rapid eye movement (REM) sleep (Garcia-Rill 1991). This theory has been supported by
the comorbidity of sleep disturbances and the later onset of motor and cognitive decline
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seen in progressive neurodegenerative disorders such as Parkinson’s disease and
progressive supranuclear palsy (PSP), where there is selective loss of cholinergic neurons
in the PPT as well as other neuronal populations (Raggi and Ferri, 2010). Additionally,
this is supported by anatomical studies of the PPT. The PPT projects directly to the
thalamocortical system and also to the basal forebrain, both of which cause cortical
activation during waking and REM sleep (Petrovic et al., 2013).
To clarify the role of the PPT in REM sleep regulation, Petrovic et al. (2013)
lesioned the PPT bilaterally in rats and evaluated the effect on sleep-wake states using
EEG. These studies showed that the lesions did not affect the sleep/wake cycle, but it did
alter the structure of the sleep-wake transitions. There was an increase in the number of
Wake/REM and REM/Wake transitions that was sustained for 5 weeks after the
surgeries. The EEG showed that the lesions increased the Wake theta amplitude and the
REM beta amplitude, demonstrating increased cortical activation (Petrovic et al., 2013).
Robust firing of midbrain dopaminergic neurons have been observed during REM
sleep, concurrent with ACh and glutamate release from the PPT onto nigrostriatal
dopaminergic neurons (Dahan et al., 2009). It has been proposed by Lima (2012) that the
release of glutamate and ACh from the PPT onto the substantia nigra and VTA causes a
dopaminergic release onto the reticular formation causing the activation of REM sleep.
Degeneration of cholinergic signaling from the PPT disrupts this pathway and leads to
sleep pathologies, which is often comorbid with PD motor symptoms (Lima 2012).

3

Rationale and Hypothesis
The physiological role of ACh released from cholinergic neurons from the

pedunculopontine tegmental nucleus (PPT) is still poorly understood. Here, we generated
mice with VAChT deletion selectively from PPT cholinergic neurons to investigate how
ACh signaling from this nucleus contributes to different brain functions. This provides
the opportunity to evaluate the consequences of decreased cholinergic signaling from the
PPT in vivo.
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Based on the efferent connectivity from the PPT, our hypothesis is that decreased
cholinergic signaling from the PPT will affect specific behavioural outputs such as gait,
motor control and sleep.
Improving our understanding of cholinergic signaling from the PPT and how it
relates to behavioural abnormalities may lead to the development of novel treatments for
the symptoms of neurological diseases such as PD and PSP.

4

Methods

4.1 Ethics Statement
All experiments were carried out following guideline set by the Canadian Council of
Animal Care (CCAC), with the protocol approved by the University of Western Ontario
Institutional Animal Care and Use Committee (protocol 2008-127). Only male mice were
used in the behavioural studies. Mice were housed two to four per cage in a room with a
14-hour light/10-hour dark cycle, and provided access to food and water ad libitum.

4.2 Animals
Pedunculopontine tegmental nucleus-specific VAChT knockout mice (VAChTEn1-Creflox/flox

) were generated using a Cre recombinase/LoxP system. In short, VAChTflox/flox

mice (Martins-Silva et al., 2011; mixed C57BL/6J x 129/SvEv background, backcrossed
to C57BL/6J for five generations) were crossed with the En1-Cre mice (Jackson
Laboratories, stock no. 007916; Kimmel et al., 2000; mixed 129S1/SvImJ background,
backcrossed to C57BL/6J in our laboratory for at least two generations). We then
intercrossed VAChTEn1-Cre-flox/wt mice to obtain VAChTEn1-Cre-flox/flox. Control mice used
in our experiments are littermates VAChTflox/flox. Only male VAChTEn1-Cre-flox/flox mice
greater than three months of age were used in these experiments with male VAChTflox/flox
age-matched controls.
Rosa26-tdTomato

mice

(B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J,

Jackson

Laboratories, stock no. 007914; Madisen et al., 2010) have a loxP-flanked STOP cassette
to prevent the transcription of the downstream red fluorescent protein variant, tdTomato.
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These mice were bred to mice expressing Cre recombinase under the control of the En1
promoter (En1-Cre mice). The offspring generated as a result of this breeding express
dTomato

in

all

Cre-expressing

tissues.

These

mice

were

analyzed

by

immunohistochemistry to determine the brain regions where En1-Cre is expressed in
cholinergic neurons.

4.3 Immunohistochemisty and Western Blots
For the immunofluorescence experiments, mice were anesthetized with ketamine
(100mg/kg)-xylene (20 mg/kg) then perfused transcardially with 4% paraformaldehyde
(v/v) in phospho-buffered saline (PBS) (pH 7.4). Brains from VAChTEn1-Cre-flox/flox mice
and VAChTflox/flox mice were removed and incubated in 4% paraformaldehyde in PBS
overnight at 4°C. Brains were sectioned in the sagittal plane using a vibratome (40 µm
thick) and transferred into a six well plate with each well containing PBS. Slices were
place one per well in a clockwise manner. All slices within only one well were selected
for immunohistological analysis. These selected free-floating slices were then washed
with Tris-buffered saline (TBS) (pH 7.6) 3 times for 15 minutes then blocked and
permeabilized by incubation for 1 h at room temperature in TBS with 0.2% Triton X-100,
3% bovine serum albumin (w/v), and 5% normal horse serum. Sections were then
incubated for 48 hours at 4°C with mouse anti-CHT1 (high-affinity choline transporter 1)
(catalog #ab5966; Millipore) at a 1:500 dilution in 1:1 TBS and blocking solution. Slices
were washed 3 times for 15 min in TBS with 0.1% Tween20 (TBST), brain slices were
incubated with the seconday antibody (an Alexa488 dye-conjugated rabbit anti-mouse
IgG; catalog #a6662; Abcam) in 1:1 TBS and blocking buffer overnight at 4°C. Sections
were washed five times for 10 minutes in TBS then mounted on slides with
Immunomount (Thermo Scientific, Massachusetts, USA) and visualized using Leica-SP5
laser-scanning microscope using an argon laser and HeNe1 laser. Images were taken
using Leica SP5 fluorescence microscope with a 40x oil immersion objective (1.25 NA).
For each mouse, one image of each brain region was quantified and the percent
colocalization of tdTomato and CHT1-labelled neurons was quantified. This value was
obtained for four mice from each genotype and averaged.
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For Western blot analysis, fresh brain tissue was used from both VAChTEn1-Cre-flox/flox
mice and VAChTflox/flox control mice. To prepare extracts, tissues were homogenized in
buffer containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X100 and protease inhibitor cocktail. Extracts remained at 4oC for 20 minutes then
centrifuged (10,000 x g x 20 min). Protein concentration of the supernatant was
determined using the Bradford method. 50 µl of protein was loaded into precast 12% gels
(Lonza; Basel, Switzerland) and run for 90 minutes at 120 volts. Protein was then
transferred to PVDF membrane using Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad;
Hercules, CA). For immunoblotting, membranes were washed with TBS with 0.05%
Tween20 (TBST) for 10 minutes then incubated with blocking solution (5% milk in
TBST) for one hour. Membranes were then incubated in primary antibody at 4oC
overnight diluted in blocking solution. Antibodies were rabbit anti-VAChT (catalog
#139103; Synaptic Systems) at a 1:3000 dilution and mouse anti-Synaptophysin (catalog
#S5768; Sigma-Aldrich) at a 1:500 dilution. After, membranes were washed with TBST
three times for fifteen minutes each. Membranes were developed using Amersham ECL
Plus reagent kit (GE Life Sciences; Pittsburgh, PA). Non-saturated autoradiographs were
analyzed with ImageJ.

4.4 Grip Strength and Wire Hang
A Grip Strength Meter from Columbus Instruments (Columbus, OH) was used to
measure forelimb grip strength (Prado et al., 2006; Deacon, 2013). Mice grasped the
smooth pull bar of the apparatus with forelimbs only and then were pulled backwards by
the tail horizontally. The force applied to the bar immediately before grasp was released
was recorded. 3 measurements were recorded per animal and averaged. The inter-trial
interval for each mouse was 30 seconds, during which the mouse was returned to its
home cage.
For the Wire Hang test (Prado et al., 2006; Deacon, 2013), each mouse was placed on
a metal wire-grid, which was slowly inverted and suspended 40 cm above a piece of
foam. The time for each mouse to fall from the wire was recorded with a 60s cut-off. The
inter-trial interval for each mouse was 30 seconds, during which the mouse was returned
to its home cage.
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4.5 Open Field Locomotion
To measure spontaneous locomotor activity in new environments (Pierce and Kalivas,
2007; de Castro et al., 2009), mice were placed in an open field arena (20 cm x 20 cm
platform with 30 cm high walls) and movement in the arena was recorded by VersaMax
Animal Monitoring System from AccuScan Instruments Inc. (Columbus, OH). Mice were
placed in the centre of the apparatus and allowed to freely explore the novel environment
for 120 minutes in the light followed by 120 minutes in the dark. VersaMax converts
infrared beam breaks into movement (cm) per 5-minute interval. For intersession
habituation, mice spent 120 min in the same open field apparatus for three consecutive
days. Measurements of total activity were obtained.

4.6 Rotarod
For the rotarod task (Prado et al., 2006; de Castro et al., 2009), mice were placed on
the accelerating rotarod apparatus (San Diego Instruments; San Diego, CA) for ten trials
with an inter-trial time of 10 minutes during which mice were placed in their home cage.
On the second day the animals underwent four more trials with the same conditions from
the previous day. Animals were allowed to acclimate to the rod for 5 seconds before the
trial started. For the first 100 seconds the revolutions per minute (RPM) was 5, then 15
RPM for the subsequent 100 seconds, then 25 RPM for the next 100 seconds and finally
35 RPM for the final 100 seconds. The software records latency to fall. Rod was cleaned
with 70% ethanol between trials.

4.7 CatWalk Gait Analysis
The CatWalk XT system by Noldus (Leesburg, VA) was used to assess the gait of the
animals (Koopmans et al., 2005). The apparatus is made of a 1.3 m long glass plate with
dim fluorescent light beamed into the glass from the side. The paw in contact with the
glass was recorded by a video camera underneath the walkway. Mice were allowed free
exploration of the walkway for 1 min. Three correct runs (the mouse crossed the
walkway with no interruption or hesitation) for each mouse was recorded. Runs were
analyzed using the Noldus software. Stride length is defined as the distance between two
successive prints of the same paw.
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4.8 Metabolic cages
Oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory
exchange ratio (RER), food and water intake, and physical activity were simultaneously
measured using the Comprehensive Lab Animal Monitoring System (CLAMS) interfaced
with Oxymax software (Columbus Instruments; Columbus, OH) (Guzman et al., 2013).
Mice were housed individually in the metabolic chambers maintained at 24 ± 1°C. Mice
had free access to powdered standard rodent chow and water. Mice had a 24 h habituation
period, after which measurements were taken every 10 min for 24 h (12-h light/ 12-h
dark). VO2, CO2, RER, food and water intake, ambulatory activity, and sleep (periods of
inactivity) measurements were obtained using the Opto-M3 Activity Monitor and
Oxymax software algorithms (Columbus Instruments; Columbus, OH).

4.9 Forced Swimming Test and Tail Suspension Test
The forced swimming test (FST) and tail suspension test (TST) were used to measure
depressive-like behaviour (Martyn et al., 2012). For FST, mice were placed in the testing
room and allowed to habituate for one hour. Mice were placed in a 2 L beaker with 1.8L
of 25-27oC water for 6 min. A video monitor was placed above the beaker and using
ANYmaze software (Stoelting Co., IL) the time spent immobile and distance swam were
calculated. Only data taken from 2-6 minutes were analyzed. Water was changed every 23 mice.
For the TST, mice were suspended from a bar 30 cm above a table by their tail, using
masking tape placed 1.5 inches from the base of the tail, for 6 min (Martyn et al., 2012).
Sessions were recorded and immobility time and immobility episodes were quantified
using ANY-Maze software (Stoelting Co., IL).

4.10 Elevated Plus Maze
The elevated plus maze is used to investigate murine anxiety (Martins-Silva et al.,
2011). The elevated plus maze is a plus-shaped platform with two open arms and two
arms with dark plastic walls. Mice were placed in the centre facing the open arm opposite
the experimenter. Mice were allowed to explore the maze for 5 minutes then they were
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returned to their home cage. A video monitor was placed above the maze and total
amount of time spent in the open or closed arms of the maze, as well as total distance
travelled, was calculated with the Any-maze software (Stoelting Co., IL). Mice were
considered to be completely within an arm of the maze when its centre of gravity was in
that section. All parts were cleaned between animals, first with soap and water followed
by 70% ethanol.

4.11 Light/Dark Place Preference Test
The light/dark place preference test is used to evaluate anxiety-like behaviour
(Martyn et al., 2012). A black plexiglass insert that is exactly half the area of the open
field arena (20 cm x 20 cm platform with 30 cm high walls) is placed in the arena. The
black insert has a small opening in the front to allow the mouse to move freely between
the open half of the arena or the dark covered half inside the insert. The test is done with
the mice 30 min into their wake cycle (19:30 h) in a bright room. Mice are placed in the
centre of the arena and ambulatory activity in a 10 min session is recorded using the
VersaMax Animal Activity Monitoring System (AccuScan Instruments, Inc.; Columbus,
OH). All parts were cleaned between animals, first with soap and water followed by 70%
ethanol.

4.12 Marble Burying Task
The marble burying task considered presently to be a measure of repetitive,
compulsive-like behaviours in mice, although it is still commonly used as a measure of
anxiety-like behaviour in rodents (Angoa-Perez et al., 2013; Thomas et al. 2009). 20
glass marbles are arranged evenly on the surface of clean cage partitioned in half with
bedding that is 2 inches deep. The number of marbles buried in a 15 minute session is
counted. A marble must be 2/3 covered in bedding to be considered buried.

4.13 Morris Water Maze
Spatial memory was assessed using the spatial version of the Morris water maze
(MWM) (Vorhees and Williams, 2006; Martyn et al., 2012; Kolisnyk et al., 2013).
External cues were placed around a circular tank, 120 cm in diameter, filled with water at
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a temperature of 25°C. A circular, clear escape platform, 10 cm in diameter, was placed
0.5 cm below the surface, such that it was hidden underneath the waterline but still
mountable. The tank was conceptually divided into four quadrants. Testing was done on
five consecutive days. On the first four days, the platform was kept in a constant position
for each mouse. The mouse underwent four trials on each day, starting once at the
dividing line between each quadrant facing the edge of the tank. 90 s were given for the
mouse to reach the platform, with its path analyzed using a video monitor placed over the
tank and ANY-maze software (Stoelting Co., IL). If task was not completed in 90 s, the
mouse was guided to the platform. The inter-trial interval was 15 minutes. On the fifth
day, one trial was done for each mouse with the platform removed from the tank. The
mouse was placed directly opposite of the where the platform used to be, and was given
60 s swim around the tank. Time spent in the target quadrant was measured using ANYmaze software (Stoelting Co., IL).
The cued version of the MWM was performed to assess goal-directed behaviour
(Rossato et al., 2006). For this variation, the platform was at water level and visible with
a plastic block cue placed on it, and spatial cues were removed from the room. Mice were
tested over two days with novel platform and starting location combinations. Mice
underwent 8 consecutive training trials with a 30 s inter-trial interval on day 1. After 24 h
the mice are probed for their retention of the trials but undergoing 2 cued trials, this time
starting from a position that was not used during training.

4.14 Spontaneous Alternations Y-Maze Task
Working memory is evaluated using the spontaneous alternations Y-maze task
(Hughes 2004). Test was performed using a symmetrical Y-shaped maze (30 cm long by
6 cm wide by 20 cm high) following a protocol previously described (de Castro et al.,
2009; Kolisnyk et al., 2013). Mice were placed at the end of one arm and allowed to
freely explore the maze for 8 min. A spontaneous alternation occurred when the mouse
visited all three arms of the maze in sequence without revisiting a previous arm. All
sessions were recorded and the order and number of arm entries were measured by Anymaze software (Stoelting Co., IL). The effect was calculated as percentage alternation
according to the formula: [total alternation/(total arms entered - 2)] x 100. Therefore, the
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following hypothetical sequence of arms entered by a mouse: A,C,A,B,C,A,C,B,A,C
would yield an alternation score of 75% ([6 alternations/(10-2) arms entered] x 100). A
score of 50% means random selection of goals arms. Animals statistically reach more
than 50% alternation, indicating no random arms selection. By this criterion, we would
see 100% alternation score only if the animal had run consistently clockwise or
anticlockwise.

4.15 5-Choice Serial Reaction Time Task
4.15.1

Pre-training Phase

The five-choice serial reaction time task (5-CSRTT) is used to determine attention
in mice (Robbins 2002; Romberg et al., 2011). Mice were trained in the 5-CSRTT in
automated Bussey-Saksida Mouse Touch Screen Systems model 81426 (Campden
Instruments Limited; Lafayette, IN). Schedules were designed and data were collected
using the ABET II Touch software v.2.15 (Lafayette Instruments; Lafayette, IN).
Mice first were gradually food restricted and reduced to 85% of their normal
weight before undergoing a pre-training program that was previously described by
Kolisnyk et al. (2013) that involved habituating the mouse to the testing chamber for 15
minutes. The following day, the mouse spent 20 min in the chamber, during which the
reward tray was illuminated and primed with strawberry milkshake (Saputo Dairy
Products). Whenever the mouse went to the reward tray, it received the reward paired
with a tone. The mouse repeated this process for two more days, each with 40 min
duration.
In the next pre-training phase, the mice learn to pair the reward with a stimulus (a
flash of light in one of the 5 windows) on the touchscreen. The stimulus appeared at
random and remained for 30 s, after which it was removed and a reward paired with a
tone was given (one trial). Once the mouse collected the reward another trial was
initiated. This phase was continued until the mouse successfully completed 30 trials
within a 60 min session.
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The third phase of pre-training involved teaching the mouse to touch the stimulus
on the screen. If the mouse touched the stimulus on the screen it received the reward
paired with the tone. If the mouse touched the screen in where there was no stimulus
there was no response. This phase was repeated until the mouse consistently completed
30 trials in a 60 min session.
Phase 4 was the same as phase 3, which the difference that the mouse had to nose
poke the reward tray to initiate the trial. This phase was repeated until the mouse
completed 30 trials in a 60 min session.
In the final pre-training phase (phase 5), the mice underwent the same procedure
as in phase 4, but if the mouse touched one of the 5 screens that did not display the
stimulus (an incorrect screen), it received a 5 s timeout, which was indicated by the
chamber light turning on during this time. Mice must perform this phase with a minimum
of 80% accuracy (at least 23 correct responses within 30 trials) within the 60 min session.
This level of accuracy must be sustained for 2 consecutive days in order for the mouse to
progress to 5-CSRTT training phase.

4.15.2

5-CSRTT Training Phase

In this phase, mice learn to respond to flashes of light pseudo-randomly displayed
in one of the 5 locations on the touchscreen. The mouse nose pokes the reward dispenser
to initiate the trial. There is a variable 5-10 s delay period during which the mice must
attend to the screen, after which the light stimulus appeared on the touch screen. There
was a 5 s period after the stimulus presentation where the mouse could still respond to the
location (holding period). If the mouse touched the screen during the delay period, the
response was recorded as premature and the mouse was punished with a 10 s timeout. A
response to the stimulus window during stimulus presentation or during the holding
period was recorded as a correct response. Responses to any other window were recorded
as incorrect. Correct response was rewarded with the milkshake and tone pairing and an
incorrect response was punished with a 10 s timeout. Failure to make any response was
recorded as an omission and the mouse was punished with a 10 s timeout. Perseverative
responses to the screen after either a premature, correct, or incorrect choice was also
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recorded. Each session lasted until 50 trials were completed to a maximum duration of 1
h. Once the mice reached the criterion at 4 s stimulus duration of a minimum of 30 trials,
80% accuracy, and 20% omissions for 3 consecutive days, the stimulus duration was
reduced to 2 s. After mice reached this same criterion for the 2s stimulus duration, the
mice were tested 2 more days, and the average of those measures was recorded as their
baseline performance.

4.15.3

Probe trial

After the baseline measures had been recorded, the mice were probed for
attentional deficits in the following probe trial schedule: 2 d at 1.5 s stimulus duration, 2
d at 1.0 s stimulus duration, 2 d at 0.8s stimulus duration and finally 2 d at 0.6 s stimulus
duration (Kolisnyk et al., 2013). The order of these probe trial sessions were semirandomized using a Latin square method.

4.15.4

5-CSRTT measurements

On all 5-CSRTT sessions, accuracy was defined as: [(number of correct
responses)/(total number of correct and incorrect responses)]. Rate of omissions was
defined as: [(number of omitted responses)/(total number of responses)]. Response
latency was defined as the duration of time between the initiation of the trial and the first
touch of the correct stimulus. Reward collection latency was the duration of time between
the mouse touching correct stimulus and then returning to the reward tray. A premature
response was counted when the mouse touched any one of the 5 windows before the
stimulus onset. A perseverative response was any identical response that occurred after
either a correct, incorrect, or premature response. (Kolisnyk et al., 2013)

4.16 Statistical analysis
Data are expressed as mean ± SEM. Prism 5 and SigmaStat 3.5 software was used for
statistical analysis. Comparison between two experimental groups was made by Student's
t test. When several experimental groups or treatments were analyzed, two-way ANOVA
or two-way ANOVA with repeated measures was used as required. When appropriate, a
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Bonferroni post hoc comparison test was used. In all comparisons, p < 0.05 was
considered statistically significant.
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Chapter 2

5

Results

5.1 Immunohistochemistry and Western blot analysis of
VAChTEn1-Cre-flox/flox mice
In order to selectively eliminate VAChT in the PPT, VAChTEn1-Cre-flox/flox mice were
generated using a Cre-loxP system under the control of the regulatory elements
(homeobox transcription factor 1) encoded by the En1 gene (Kimmel et al., 2000). The
En1 gene was selected to drive Cre recombinase expression because its expression is
restricted to the mes/r1 (Kimmel et al., 2000). Previous studies using the En1-Cre
driverline have found Cre activity in cholinergic neurons of the rostral brainstem
(including the PPT) but no activity in the more caudal motor neurons in the brainstem
(Machold 2013). To test whether Cre was expressed in PPT cholinergic neurons, a
reporter mouse line was used to reveal the location of En1-cre expression. The reporter
line used was the Rosa-26-tdTomato mice, in which the Rosa26 locus expresses
tdTomato once Cre-mediated recombination has occurred. En1-Cre mice were crossed
Rosa-26-tdTomato mice and immunofluorescence analysis of En1-Cre:Rosa-26tdTomato mice brain slices used to investigate location of Cre expression driven by the
En1 promoter. The number of neurons revealing colocalization between tdTomato- (red)
and CHT1-labelled neurons (green) was divided by the total number of cholinergic
neurons in the PPT (shown in Table 1) to give a percentage of colocalization for each
animal. Colocalization (Fig. 6a) was observed on average in 40% of cholinergic neurons
in the PPT and in 10% of cholinergic neurons in the Mo5 motor nuclei, but no
colocalization was observed in the 7N motor nuclei, the striatum, and the cortex (Fig. 5;
Table 1). Sagittal brain slices were selected to reflect the cholinergic nuclei at
approximately the same lateral position in each animal. It should be noted that the most
medial slice of the PPT did not have any colocalization between td-Tomato- and CHT1labelled neurons, so the percent colocalization may not be consistent throughout the
entirety of the PPT. We subsequently intercrossed En1-Cre mice with VAChTflox/flox mice
to generate mice with a selective elimination of VAChT in the PPT.
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Table 1. Summary of the number of YFP-labeled neurons colocalizing with CHT1labeled cholinergic neurons in the immunohistological analysis of the En1-Cre:Rosa26-tdTomato mouse line. Values are expressed as the number of YFP- and CHT1colabelled neurons out of total number of CHT1-labelled neurons in the image
obtained for that brain region in each mouse.
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To indirectly assess the degree of Cre-mediated recombination, Western blot analysis
of VAChTEn1-Cre-flox/flox mice was performed to evaluate VAChT protein expression. In the
brainstem, there was 50% decrease in VAChT protein levels (t(6) = 5.123, p = 0.0018;
Fig. 6a). In the thalamus, the primary output centre of the PPT, there was 90% decrease
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in VAChT protein levels (t(6) = 3.369, p = 0.0151; Fig. 6b), suggesting that most of the
Cre-targeted neurons project to this brain area. The hippocampal blot shows a trend that
suggests the VAChTEn1-Cre-flox/flox mice have twice as much VAChT as controls, however
this increase is not significant (t(6) = 2.434, p = 0.0509; Fig. 6d). VAChT protein levels
in the striatum (t(6) = 1.524, p = 0.1785; Fig. 6c) and the cortex (t(6) = 1.273, p = 0.2503;
Fig 6e) were not significantly affected.
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Figure 6. VAChT protein expression. Western blot analysis shows VAChT
knockdown in (a) the brainstem, and (b) the thalamus. VAChT protein levels are
not significantly changed in (c) the striatum, (d) the hippocampus and (e) the cortex;
n = 4. Data analyzed using Student’s t-test; *, p < 0.05, **, p < 0.01.
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5.2 Behavioral analysis of En1-Cre mice
To test whether the presence of Cre recombinase under the control of the En1
promotor did not affect the behavioural phenotypes in the genetically modified mice, we
compared the behaviours of wildtype (WT) mice with En1-Cre mice in a number of
tasks.
First, we evaluated locomotor activity of these En1-Cre animals using automated
locomotor boxes to evaluate spontaneous locomotor activity in a novel environment (Fig.
7) and habituation. En1-Cre mice were not different from wild-type controls in their
short-term habituation to the novel locomotor boxes (F(1,17) = 0.15, p = 0.748) (Fig. 7a)
or in their total distance covered over the three days of testing (F(1,17) = 0.17, p =
0.6859) (Fig. 7b).
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Figure 7. En1-Cre mice have normal spontaneous locomotor activity. (a) short-term
habituation in locomotor boxes over two hours on day 1. (b) long-term habituation
over three days, shown by total distanced travelled during each day. Data expressed
as mean ± SEM and analyzed using repeated measures two-way ANOVA. WT n =
13, En1-Cre n = 9.
We also evaluated locomotor activity in a “familiar” environment during their
wake (dark) and sleep (light) cycles (Fig. 8). No difference between controls and En1Cre mice was observed in the distance travelled during the light and the dark phase
(F(1,21) = 0.24, p = 0.6322) (Fig. 8).
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Figure 8. En1-Cre mice have normal spontanous locomotor activity during their
sleep and wake cycles. Data expressed as mean ± SEM and analyzed using a
repeated measures two-way ANOVA. WT n = 13, En1-cre n = 10.
We then used the grip strength test (Fig. 9) as well as the rotarod test to evaluate
neuromuscular functioning (Fig. 10). In the grip strength test, there was no significant
difference between the force applied to the grip strength apparatus by the forelimbs (t(21)
= 1.330, p = 0.1979) (Fig. 9a) or by the hindlimbs (t(21) = 0.5721, p = 0.5733) (Fig. 9b).
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Figure 9. En1-Cre mice have no physical abnormalities in the grip strength. (a)
Forelimb grip strength and (b) hindlimb grip strength. Data expressed as mean ±
SEM and analyzed using a Student’s t-test. WT n = 13, En1-cre n = 10.
During the rotarod task En1-Cre mice did not significantly differ from their
controls in their latency to fall off the rod (F(1,21) = 2.37, p = 0.1383) (Fig. 10a) or their
distance travelled during the task (F(1,21) = 2.27, p = 0.1468) (Fig. 10b). Together, these
data suggest that the presence of Cre recombinase did not alter the neuromuscular
functioning of the En1-Cre animals.
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Figure 10. En1-Cre mice have normal neuromusclar functioning in the rotarod task.
(a) Latency to fall of the rotating rod and (b) distance travelled on during the trial.
Data expressed as mean ± SEM and analyzed using a repeated measures two-way
ANOVA. WT n = 13, En1-cre n = 10.
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Taken together, these data indicate that the En1-Cre mice are physically similar to
control WT mice. We next tested the mice for the presence of psychiatric-like phenotypes
such as depressive-like behaviour and anxiety-like behaviour. To look for the presence of
psychiatric-like phenotypes in these animals, we used the forced swim test, the tail
suspension test (Figure 11), and the elevated plus maze (Figure 12).
In the forced swimming test, the En1-Cre mice did not significantly differ from
WT mice in time spent immobile during the final four minutes of the test (t(12) = 0.8330,
p = 0.4211; Fig. 11a) or in their total distance swam during the test (t(19) = 0.3285, p =
0.7461; Fig. 11b). This was supported by the results from the tail suspension test, in
which the En1-Cre mice again were not different from controls in the total time spent
immobile during the test (t(19) = 0.1814, p = 0.8579; Fig. 11c) or in the number of
immobility episodes (t(18) = 1.011, p = 0.3254; Fig. 11d). Thus, the presence of Cre
recombinase under the control of the En1 promoter does not appear to cause a depressivelike phenotype in these animals.
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Figure 11. En1-Cre mice do not have a depressive-like phenotype in the forced
swimming test or the tail suspension test. (a) Time spent immobile and (b) distance
swam during the forced swimming test. (c) Time spent immobile and (d) number of
immobility episodes in the tail suspension test. Data expressed as mean ± SEM and
analyzed using a Student’s t-test. WT n = 13, En1-cre n = 10.
The elevated plus maze was used to evaluate anxiety-like behaviour. En1-cre
mice spent the same percentage of time on the closed and opened arms of the maze and in
the centre of the maze as the WT controls (F(1,63) = 0.001, p = 0.9932; Fig. 12a).
Additionally, the En1-Cre mice made the same number of entries into the open arms of
the maze as the WT mice (t(20) = 0.7555, p = 0.4587; Fig. 12b). This suggests that the
En1-Cre mice do not demonstrate anxiety-like behaviour.
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Figure 12. En1-Cre mice do not have anxiety-like behaviour in the elevated plus
maze. (a) Percentage of time spent in the close and open arms as well as the centre of
the elevated plus maze. (b) Total number of entries into the open arm of the elevated
plus maze. Data expressed as mean ± SEM. (a) Analyzed using a two-way ANOVA
and (b) analyzed using a Student’s t-test. WT n = 13, En1-cre n = 10.
Finally, to assess cognitive functioning, we evaluated these mice in the Morris
water maze (Figure 13) to assess changes to learning and memory. In the spatial version
of the Morris water maze, the En1-Cre mice were not different from the WT mice in their
latency to find the hidden platform over the four acquisition days of this test (F(1,16) =
0.89, p = 0.3595; Fig. 13a). During the probe trial, there was no significant difference
between the two genotypes in their time spent in each quadrant during the probe trail
(F(1,16) = 0.04, p = 0.8409; Fig. 13b). Tukey post hoc analysis revealed the both the WT
mice (p = 0.0041) and the En1-Cre mice (p = 0.0125) spent significantly more time in the
target zone than the other three quadrants of the tank. Path tracings are representative of
WT (Fig. 13c) and En1-Cre (Fig. 13d) mice during the probe trial. These data indicate
that the En1-Cre mice have no deficits in spatial learning and memory.
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Figure 13. En1-Cre mice show normal learning and memory capabilities in the
spatial version of the Morris water maze. (a) Latency to find the hidden platform
during the four acquisition days and (b) percentage of time spent in each quadrant
of the tank during the probe trial. T = target, L = left of target, R = right of target
and O = opposite from target. (c) Representative path tracings of WT mice and (d)
representative path tracings of En1-Cre mice. Target quadrant is the lower left
segment of the path tracing image. Data expressed as mean ± SEM. (a) Analyzed
using a repeated measures two-way ANOVA and (b) analyzed using a two-way
ANOVA. *, p < 0.05, **, p <0.01. WT n = 11, En1-cre n = 8.

Since En1-Cre mice were not different from controls in any of the behavioural
parameters it was clear that the presence of Cre recombinase under the En1-Promotor did
not impart any abnormalities on these animals. As such, we next assessed the VAChTEn1Cre-flox/flox

mice for deficits resulting from the loss of cholinergic signaling from the PPT.
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5.3 Behavior analysis of of VAChTEn1-Cre-flox/flox mice
5.3.1

Locomotor activity and neuromuscular functioning
Since the PPT is thought to be involved in motor control (Alderson et al., 2008;

Takakusaki 2008), a number of tests for locomotor activity and neuromuscular
functioning were performed to test whether there will be any behavioural differences
between control and VAChTEn1-Cre-flox/flox mice.
Spontaneous locomotor activity was evaluated in an automated locomotor box.
Mice were allowed to habituate in the box for two hours on Day 1 (short-term
habituation). Long-term habituation was also measured in the locomotor box over two
subsequent days. Total distance travelled over the two-hour period was calculated. There
was no statistical difference between the distance travelled by VAChTEn1-Cre-flox/flox mice
and control littermates over the two-hour period on Day 1 (F(1,23) = 0.4546, p = 0.5055;
Fig. 14a) or between their ability to habituate to the locomotor boxes over three days
(t(1,79) = 1.74, p = 0.9430; Fig. 14b). In summary, there were no apparent deficits in
locomotor activity or habituation to a novel environment in the VAChTEn1-Cre-flox/flox mice.
To further assess neuromuscular function in VAChTEn1-Cre-flox/flox mice, two tests
were used: the wire hang test and the grip strength test. For both the wire hang (t(19) =
1.165, p = 0.2585) and grip strength (t(19) = 1.306, p = 0.2073) tests there was no
statistical difference between VAChTEn1-Cre-flox/flox mice and control littermates (Fig. 14cd).
The accelerating rotarod task was used to assess motor learning. Both VAChTEn1Cre-flox/flox

mice and control littermates improved the time spent on the rotarod as well as

distance traveled and there was no significant difference between genotypes in the
latency to fall (F(1,15) = 0.88, p = 0.3618) or distance travelled (F(1,15) = 0.56, p = 0.3302)
(Fig. 14e-f).
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Figure 14. VAChTEn1-Cre-flox/flox mice have normal spontaneous locomotor activity
and neuromuscular functioning. (a) short-term habituation in locomotor boxes over
two hours on day 1. (b) long-term habituation over three days, shown by total
distanced travlled during each day. (c) duration of time on inverted wire mesh and
(d) force applied by forelimbs to grip a wire. (e) latency to fall of rotarod and (f)
distance covered during rotarod test. Data expressed as mean ± SEM. (a-b) analyzed
using repeated measures two-way ANOVA, (c-d) analyzed using a Student’s t-test,
and (e-f) analyzed using repeated measures two-way ANOVA. (a-d) VAChTflox/flox n
= 15, VAChTEn1-Cre-flox/flox n = 12, (e-f) VAChTflox/flox n = 10, VAChTEn1-Cre-flox/flox n =
7.
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5.3.2

Metabolism and Sleep

Metabolic activity was measured using metabolic cages over a 48-hour period and
data from the last 24 hours was analyzed. In these closed system chambers, mice were
evaluated for oxygen consumption (Fig. 15a), carbon dioxide production (Fig. 15b),
resting energy expenditure (RER) (Fig. 15c) and heat production (Fig 15d), as well as
food and water intake (Fig. 15e-f). No significant difference was observed between
VAChTEn1-Cre-flox/flox mice and VAChTflox/flox controls in their VO2 (F(1,30) = 0.53, p =
0.4740), VCO2 (F(1,30) = 0.54, p = 0.4667), RER (F(1,30) = 0.12, p = 0.7301) or heat
production (F(1,30) = 1.57, p = 0.2202), indicating that decreased VAChT expression in
the PPT did not alter metabolism. Additionally, there was no significant difference
between genotypes in food (F(1,30) = 0.88, p = 0.3568) or water (F(1,30) = 0.25, p =
0.6189) consumption.
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Figure 15. No difference in metabolism between VAChTEn1-Cre-flox/flox mice and
controls. Metabolic parameters were measured over a 48-hour period, with the data
from only the last 24 hours analyzed. The light and dark periods are two
consecutive 12-hour periods within those 24 hours analyzed. (a) oxygen
consumption, (b) carbon dioxide consumption, (c) resting energy release (RER), (d)
heat production, (e) food intake and (f) water intake. Data expressed as mean ±
SEM, and analyzed using a two-way ANOVA. VAChTflox/flox n = 7, VAChTEn1-Creflox/flox
n = 10.
A feature of the metabolic cages is the ability to measure the animal’s sleep
through assessing time spent immobile in the cage versus time in motion (Guzman et al.,
2013). The number of sleeping bouts, average duration of these bouts, and total time
spent sleeping was measured for both the light and dark phases of the test. While there
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was no significant different in the number of sleeping bouts (F(2,45) = 0.66, p = 0.5213;
Fig. 16a) or the average duration of these bouts (F(1,45) = 0.10, p = 0.9020; Fig. 16c),
Bonferroni post hoc revealed a significant decrease in the time spent sleeping during the
dark phase of the test (the animal’s wake cycle) (F(1,45) = 5.14, p = 0.0283; Fig. 16b). This
data suggests that there may be a role of PPT cholinergic signaling in the regulation of

Number of sleeping bouts

a

VAChTflox/flox
VAChTEn1-cre-flox/flox

100
80
60
40
20
0

Light

Dark

Total

Light

Dark

Total

b

Total time sleeping (h)

sleep-wake cycles.

15
10
p = 0.0283

5
0

*
Light

Dark

Total

Average duration of bouts
(min)

c
15
10
5
0

Figure 16. VAChTEn1-Cre-flox/flox mice spend significantly less total time sleeping in the
dark phase than controls. Sleep parameters were measured over a 48-hour period,
with the data from only the last 24 hours analyzed. The light and dark periods are
two consecutive 12-hour periods within those 24 hours analyzed. (a) number of
sleeping bouts, (b) total time spent sleeping, and (c) average duration of sleeping
bouts. Data expressed as mean ± SEM, and analyzed using a two-way ANOVA; *, p
< 0.05. VAChTflox/flox n = 7, VAChTEn1-Cre-flox/flox n = 10.
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5.3.3

Gait

We used the CatWalk gait analysis to evaluate any subtle alterations in gait in these
animals because the PPT is suggested to play a role in gait and posture (Rolland et al.,
2011).
VAChTEn1-Cre-flox/flox mice (aged 3-6 months) were not significantly different from
VAChTflox/flox controls in terms of the intensity of their paw print (F(1,56) = 0.05, p =
0.8186; Fig. 17a), the stride length (F(1,56) = 0.06, p = 0.8030; Fig. 17c) and the overall
normalcy of the gait (t(14) = 1.269, p = 0.2251; Fig. 17d). However, the VAChTEn1-Creflox/flox

mice demonstrated significantly smaller paw area than controls (F(1,56) = 10.32, p =

0.002; Fig. 17b). Bonferroni postests did not reveal a significant difference between
geneotypes for the paw area of a specific paw. Having a smaller paw print area suggests
that the animals are walking either on the sides of the paws or on their toes, which may
be indicative of slight postural instability.
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Figure 17. Young VAChTEn1-Cre-flox/flox mice have abnormal gait. In young mice (aged
3-6 months), (a) intensity of paw print, (b) area of paw print, (c) distance between
two prints from the same paw and (d) percent normalcy were measured. Data
expressed as mean ± SEM and analyzed using two-way ANOVA except (d) was
analyzed using a Student’s t-test; *, p < 0.05. VAChTflox/flox n = 8, VAChTEn1-Creflox/flox
n = 8.
Because of this slight change in postural stability, we also followed with a gait
analysis in older mice (12 months old). The results reflected those seen in the younger
mice, but the abnormalities were even more profound. That is, old mutant mice showed a
significant difference from controls in terms of paw area (F(1,44) = 9.34, p = 0.0038; Fig.
18b) with the area of their print being smaller. Additionally, old VAChTEn1-Cre-flox/flox mice
were significantly different from age matched VAChTflox/flox controls (F(1,48) = 8.32, p =
0.0059) in the intensity of their paw print (Fig. 18a). As for stride length, the old
VAChTEn1-Cre-flox/flox mice interestingly had a significantly longer stride length (F(1,44) =
7.58, p = 0.0086) than the control mice (Fig. 18c). For intensity, paw area and stride
length, Bonferroni post hoc did not reveal a significant difference between geneotypes for
the paw area of a specific paw. However, when the representative index was compared
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between genotypes, there was not a significant difference (t(11) = 0.8566, p = 0.4099).
The representative index is a measure of interlimb coordination when compared to
normal step sequence patterns (Neumann et al., 2009). In short, VAChTEn1-Cre-flox/flox mice
showed mild gait abnormalities in the CatWalk analysis, which is very sensitive to
evaluating the gait parameters, but when compared to a representative normal murine
gait, the overall gait of VAChTEn1-Cre-flox/flox mice did not show to be significantly
abnormal (Fig. 18d).
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Figure 18. Old VAChTEn1-Cre-flox/flox mice have abnormal gait. In old mice (aged 12
months) (a) intensity of paw print, (b) area of paw print, (c) distance between two
prints from the same paw and (d) percent normalcy were measured. Data expressed
as mean ± SEM and analyzed using two-way ANOVA except (d) was analyzed using
a Student’s t-test; *, p < 0.05. VAChTflox/flox n = 8, VAChTEn1-Cre-flox/flox n = 8.

5.3.4

Psychiatric-like phenotypes

5.3.4.1

Depression

It has been proposed that depression is a result of dysregulation of the cholinergic
system (Janowsky 1972) but to date, it is unclear which cholinergic nuclei in the brain
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may be leading to depression symptoms when disturbed. Using the VAChTEn1-Cre-flox/flox
mice we have the possibility to assess whether depressive-like behaviour is present in
animals with disruptions in cholinergic signaling from the PPT.
Depressive-like behaviour was evaluated by using the forced swim test (FST) and
the tail suspension test (Figure 19). These tests are pharmacologically validated methods
of assessing behavioural despair or depressive-like behaviour in animals. Immobility is
interpreted as hopelessness and depressive-like behaviour since rodents given
antidepressants will swim longer and spend less time immobile. The time spent
immobile, as well as the total distance swam, in the last 4 minutes of the test were
measured.

For the tail suspension test, animals will move to escape the aversive

situation, but a mouse showing increased depressive-like traits will stop struggling and
hang immobile. Here, the time spent immobile as well as the number of immobility
episodes was measured.
VAChTEn1-Cre-flox/flox mice spent significantly less time immobile than controls in
both tests (forced swimming t(16) = 2.233, p = 0.0402; tail suspension t(24) = 0.0040, p
= 0.0040; Fig. 19a and Fig. 19c, respectively). However, the VAChTEn1-Cre-flox/flox mice
did not swim a greater distance than controls in the forced swim test (t(17) = 1.551, p =
0.1394; Fig. 19b) or have a greater number of immobility episodes in the tail suspension
test (t(24) = 0.05978, p = 0.9528; Fig. 19d).
In summary, the VAChTEn1-Cre-flox/flox mice demonstrate anti-depressive-like
behaviour in both the forced swim test and tail suspension tests, suggesting that the
cholinergic signaling from the PPT may be involved in regulating depressive symptoms.
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Figure 19. VAChTEn1-Cre-flox/flox mice present antidepressive-like behaviour in the
forced swimming test and the tail suspension test. (a) immobility time in the final
four minutes of the forced swimming test and (b) total distance swam in the final
four minutes of the forced swimming test. (c) the total immobility time and (d) the
number of immobility episodes in the tail suspension test. Data expressed as mean ±
SEM and analyzed using a Students’ t test; *, p <0.05; **, p <0.01. (a-b)
VAChTflox/flox n = 7, VAChTEn1-Cre-flox/flox n = 12. (c-d) VAChTflox/flox n = 14,
VAChTEn1-Cre-flox/flox n = 12.

5.3.4.2

Anxiety

Since the VAChTEn1-Cre-flox/flox mice showed an anti-depressive-like phenotype, we
decided to test the animals for further psychiatric-like behaviours. We assessed anxietylike behaviour using a number of tests. First, we used the elevated plus maze. In this test,
the plus-shaped apparatus has two closed, dark arms and two bright open arms. The
percentage of time spent on either the open or closed arms, or in the centre, was measured
(Fig. 20a). Additionally, the number of entries into the open arm was quantified (Fig.
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20b). Mice with increased anxiety traits will spend more time in the dark, closed arms of
the maze.
In the elevated plus maze, VAChTEn1-Cre-flox/flox mice did not differ from controls
in the amount of time they spent in the closed arms, open arms, or the centre (F(1,81) =
0.001, p = 0.9400) or in the number of open arm entries (t(27) = 0.5215, p = 0.6063).
Next, anxiety-like behaviour was evaluated using the locomotor boxes. Mice are
allowed to explore the boxes freely for a two-hour period. Mice with increased anxiety
traits will spend more time in the corners of the box, whereas mice with less anxiety traits
will explore the box and spend more time in the centre. Here, total time in the centre of
the locomotor was measured (Fig. 20c). Likewise, when time spent in the centre of the
locomotor boxes was measured, VAChTEn1-Cre-flox/flox mice did not differ from controls
(t(18) = 0.3276, p = 0.7470).
Finally, the light/dark place preference test was used as an additional measure of
anxiety. In this test, a black box with a small entrance is placed inside the locomotor box
to divide it into two halves: the open half and the dark covered half. The percent of time
spent in the dark versus the light portion of the box was measured (Fig 20d).
Surprisingly, in the light/dark place preference test, VAChTEn1-Cre-flox/flox mice spent a
significantly greater time in the dark than littermate controls (t(26) = 2.401, p = 0.0238).
In summary, results from the light/dark place preference task suggested that
VAChTEn1-Cre-flox/flox mice show increased anxiety-like behaviour phenotype, however, in
the other two tests, the partial loss of cholinergic signaling from the PPT did not appear
to affect anxiety-like behaviour. Together these results suggest that if VAChTEn1-Creflox/flox

mice show an anxiety phenotype, it does not seem to be a robust phenotype.
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Figure 20. VAChTEn1-Cre-flox/flox mice demonstrate an anxiety-like phenotype in the
light/dark place preference test. (a) Percentage of time spent on the closed or open
arms or the centre of the elevated plus maze and (b) the number of entries into the
open arm of the elevated plus maze. (c) Total time spent in the centre of a locomotor
box during a two-hour period. (d) Percentage of time spent in the dark chamber
during the light/dark place preference test. (a) Data expressed as mean ± SEM and
analyzed using a two-way ANOVA and (b-d) data analyzed using a Students’ t test;
*, p < 0.05. (a-b) VAChTflox/flox n = 14, VAChTEn1-Cre-flox/flox n = 15. (c) VAChTflox/flox n
= 8, VAChTEn1-Cre-flox/flox n = 12. (d) VAChTflox/flox n = 16, VAChTEn1-Cre-flox/flox n = 12.

5.3.4.3

Compulsivity

To further characterize potential psychiatric-like behaviours of these VAChTEn1Cre-flox/flox

mice, we next assessed compulsivity or repetitive behaviours using the marble

burying task (Fig. 21). Here, twenty marbles are even spaced on top of two inches of
clean bedding in a novel cage. Mice were place in the cage for fifteen minutes and the
number of marbles buried in the bedding was quantified. Mice that buried a greater
number of marbles were considered to have more perseverative behaviour.

57

VAChTEn1-Cre-flox/flox mice buried significantly less marbles then VAChTflox/flox
control mice (t(31) =2.077, p = 0.0462), suggesting that these mice show decreased
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compulsivity compared to controls.
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Figure 21. VAChTEn1-Cre-flox/flox mice have decreased compulsive behaviours in the
marble burying task. VAChTEn1-Cre-flox/flox mice buried less marbles than controls in
the marble burying task. Data expressed as mean ± SEM and analyzed using a
Student’s t-test; *, p < 0.05. VAChTflox/flox n = 19, VAChTEn1-Cre-flox/flox n = 19.

5.3.5

Learning and Memory

5.3.5.1

Spatial memory

We tested spatial learning and memory in the VAChTEn1-Cre-flox/flox mice using the
MWM (Fig. 22). For the spatial version of this test, mice undergo 4 days of training (the
acquisition phase) to learn the location of a hidden platform. On the fifth day, the probe
trial occurs and the amount of time spent in each quadrant of the tank with the platform
removed is quantified.
During the course of acquisition, performance of VAChTEn1-Cre-flox/flox mice was
significantly different from that of controls in terms of latency to find the target (F(1,22) =
5.33, p = 0.0307; Fig. 22a). Bonferroni post hoc test analysis demonstrated that the
VAChTEn1-Cre-flox/flox mice did not improve their latency to find the target on days 3 and 4
during the acquision phase. VAChTEn1-Cre-flox/flox mice took the same time to find the
hidden platform across the four acquisition days, whereas VAChTflox/flox control mice
were able to find the platform more quickly each successive day. These results indicated
that VAChTEn1-Cre-flox/flox mice had deficits in learning the location of the platform. On the
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probe trial day, VAChTEn1-Cre-flox/flox mice showed no preference for the target quadrant of
the pool whereas the Tukey post hoc test demonstrated that the VAChTflox/flox control
mice spent significantly more time in the target quadrant (r = 0.4666, p < 0.0001) (Fig.
22b). The occupancy plots for the probe trial show that the controls remembered where
the platform should be and spent the majority of their time in this quadrant (Fig. 22c). In
contrast, VAChTEn1-Cre-flox/flox mice did not seem to recall this location during the probe
trial and primarily spent their time in thigmotaxis or passive floating (Fig. 22d).
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Figure 22. VAChTEn1-Cre-flox/flox mice show deficits in learning and memory in the
spatial version of the Morris water maze. (a) Latency to find hidden platform over 4
training days during of the spatial Morris water maze and (b) time spent in each
quadrant during probe trial; T=target, L=left of target, R=right of target and
O=opposite from target. (c) Representative plots of flox/flox mice during the probe
trial and (d) representative plots of VAChTEn1-Cre-flox/flox mice during the probe trial.
The target quadrant is the bottom right segment of the path tracing images. Data
expressed as mean ± SEM and analyzed using a two-way ANOVA; *, p < 0.05, **, p
<0.01, ***, p < 0.0001. VAChTflox/flox n = 12, VAChTEn1-Cre-flox/flox n = 12.
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5.3.5.2

Goal-directed learning

We next assessed the ability of VAChTEn1-Cre-flox/flox mice to learn and remember
the location of a visible platform that was further indicated by a large cue (Vorhees and
Williams, 2006). In the cued version of the Morris water maze, mice undergo 8 trials on
Day 1 (the acquisition phase) to learn to swim to the visible platform, and the location of
the platform and their starting point changes in each trial. On Day 2, the mice undergo
two trials but with platform location and starting point combinations they did not
experience on Day 1.
During the acquisition day VAChTEn1-Cre-flox/flox mice were significantly different
from controls (t(14) = 2.611, p = 0.0205) in terms of latency to find the target platform
(Fig. 23a). This deficit was even more pronounced during the probe trial where
VAChTflox/flox mice decreased their latency to find the cued platform and VAChTEn1-Creflox/flox

mice did not (t(14) = 4.653, p = 0.004; Fig. 23b). Examination of the path traces

confirmed that VAChTflox/flox mice swam almost directly to the platform (Fig 23c)
whereas VAChTEn1-Cre-flox/flox mice do not appear to use the cue to find the target on the
second day (Fig. 23d).
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Figure 23. VAChTEn1-Cre-flox/flox mice show deficits in learning and memory in the
cue-directed version of the Morris water maze. (a) Latency to find the visible
platform during the cued Morris water maze training day (8 trials) and (b) latency
to find the visible platform during the probe trial (2 trials). (c) Representative plots
of VAChTflox/flox mice during the probe trial and (d) representative plots of
VAChTEn1-Cre-flox/flox mice during the probe trial. The target quadrant is the bottom
segment of the path tracing images; T= Target. Data expressed as mean ± SEM and
analyzed using a Student’s t-test; *, p < 0.05; **, p <0.01; ***, p < 0.0001.
VAChTflox/flox n = 8, VAChTEn1-Cre-flox/flox n = 8.

5.3.5.3

Working memory

To further characterize the learning and memory deficits that result from a
deficiency of cholinergic signaling in the PPT, we used the spontaneous alternations YMaze to evaluate working memory in these animals (Fig. 24) (de Castro et al., 2009).
VAChTEn1-Cre-flox/flox mice and control mice had the same number of spontaneous
alternations (t(23) = 1.912, p = 0.0684; Fig. 24) in the Y maze. Performance of both
genotypes was above chance (> 50%) regarding alternations, suggesting that these mice
have no working memory deficit.
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Figure 24. VAChTEn1-Cre-flox/flox mice have normal working memory in the
spontaneous alternations Y-maze task. The percent of alternation is shown. Both
genotypes performed about chance, as indicated by the dashed line. Data expressed
as mean ± SEM and analyzed using a Students’ t-test. VAChTflox/flox n = 14,
VAChTEn1-Cre-flox/flox n = 11.

5.3.6

Attention

To determine whether VAChTEn1-Cre-flox/flox mice are affected in other cognitive
domains that are sensitive to cholinergic tone from the PPT, we used the 5-choice serial
reaction time task (5-CSRTT) (Romberg et al., 2011).

During the training phase,

VAChTEn1-Cre-flox/flox mice did not differ from controls in terms of number of training
sessions needed to achieve criterion (F(1,10) = 0.18, p = 0.6819) with a main effect of
training phase (F(2,20) = 7.12, p = 0.0046; Fig. 25). It should be noted that one mouse of
each genotype never completed the training phase and thus were removed from the
experiment and were not subjected to the 5-CSRT task. Mice were first trained using a 4
s stimulus duration and then we proceeded to 2 s stimulus duration for the 5-CSRT task
training. VAChTEn1-Cre-flox/flox mice were able to acquire the task, reaching the criteria at
both stimulus durations (2 and 4 s) in the same number of sessions as controls (F(1,10) =
0.18, p = 0.6819) with a main effect of training phase (F(2,20) = 7.12, p = 0.0046; Fig. 25).
During the 5CSRTT training phase, two VAChTflox/flox control mice and one VAChTEn1Cre-flox/flox

mouse were removed from the test due to their inability to pass the 2s stimulus

duration phase even after all other mice had completed the 5CSRTT probe trial.

Number of Training sessions
required to reach criteria
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Figure 25. Sessions to reach criteria. Number of training sessions required to meet
the criteria to pass the punish incorrect training phase, the 4s stimulus duration
training phase or the 2s stimulus duration training phase. Data expressed as mean ±
SEM and analyzed using a repeated measures two-way ANOVA. VAChTflox/flox n =
6, VAChTEn1-Cre-flox/flox n = 7.
For the probe trial, we increased the attentional demand by decreasing the
stimulus durations to 1.5 s, 1.0 s, 0.8 s and finally 0.6 s. During the probe trials,
VAChTEn1-Cre-flox/flox mice did not differ from controls in choice accuracy (F(1,10) = 0.02, p
= 0.8970) and there was a significant effect of stimulus duration (F(3,30) = 6.45, p =
0.0017; Fig. 26a). The rate of omissions for VAChTEn1-Cre-flox/flox mice was unaffected
(F(1,10) = 0.14, p = 0.7154) and there was a significant effect of stimulus duration (F(3,20) =
34.32, p < 0.0001; Fig. 26b). As for premature responses, again VAChTEn1-Cre-flox/flox mice
were not different from controls (F(1,1o) = 0.81, p = 0.3896; Fig. 26e). No change in
perseverative responses was observed in VAChTEn1-Cre-flox/flox mice (F(1,10) = 1.04, p =
0.3314; Fig. 26f). Additionally, VAChTEn1-Cre-flox/flox mice did not differ from controls in
terms of their correct response latency (F(1,10) = 0.16, p = 0.6950; Fig. 26c). There were
also no differences between genotypes in terms of reward collection latency (F(1,10) = 0.12,
p = 0.7376; Fig. 26d).
In summary, decreased cholinergic signaling from the PPT did not have a
significant affect on the attentional capacities of these animals as measured by the 5CSRTT.
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Figure 26. VAChTEn1-Cre-flox/flox mice do not show attentional deficits in the 5-choice
serial reaction time task. (a) Percent correct, (b) percent of omissions, (c) correct
response latency, (d) reward collection latency, (e) number of premature responses
and (f) total preservative correct. Data expressed as mean ± SEM and analyzed
using a two-way ANOVA. VAChTflox/flox n = 6, VAChTEn1-Cre-flox/flox n = 7.
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Chapter 3

6

Discussion
Here we investigated the role of ACh release from PPT cholinergic neurons.

Decreased cholinergic signaling from the PPT appeared to have no affect on spontaneous
locomotor activity, neuromuscular functioning, metabolism, working memory or
attention. A small but significant effect on gait and sleep was observed. VAChTEn1-Creflox/flox

mice had strong deficits in learning spatial cues in the Morris water maze and

showed deficits in goal-directed behaviours.

Additionally, an antidepressive-like

behaviour, a slight anxiety-like behaviour and reduced compulsivity were observed in
these animals. These results suggest that ACh has an important role in the modulation of
several of the physiological functions regulated by the PPT.

6.1 Analysis of VAChTEn1-Cre-flox/flox mice
We used the Rosa26-tdTomato reporter mice to elucidate the pattern of expression of
Cre recombinase driven by the En1 promoter. Our immunohistological analysis of brain
slices of these reporter mice revealed expression patterns of Cre recombinase that varied
slightly from those previously reported by Patel et al. (2012). These authors found Creexpression under the En1-Cre driver restricted to the rostral brainstem, and crossing of
En1-Cre mice with ChATflox/flox mice resulted in a complete loss of ChAT mRNA
expression in the PPT and LDT, as measured by in-situ hybridization. Here, we found
that approximately 40% of CHT1-labelled cholinergic neurons colocalized with neurons
expressing tdTomato, suggesting that around 40% of cholinergic neurons within the PPT
would have a loss of VAChT and subsequently be unable to release ACh, in contrast to
the 100% decrease in ChAT mRNA observed in the En1-Cre;ChATflox/flox mice.
Additionally, we did observe that approximately 10% of cholinergic neurons in the Mo5
motor nuclei colocalized with neurons expressing tdTomato, while Patel and colleagues
(2012) reportated that Mo5 was unaffected. Importantly, these authors created En1Cre;Tau reporter mouse line to determine the neuronal populations affected by Crerecombinase. One En1-Cre;Tau sagittal brain section from one mouse was stained by

65

immunohistochemistry for nuclear β –galactosidase (nLacZ) and VAChT. The image was
included, however no quantification of colocalization between nLacZ- and VAChTlabelling was provided, and visual examination of the image indicates much less than
100% of the VAChT-labelled neurons colocalize with the nLacZ-labelled neurons, as was
observed in our immunohistological analysis

Importantly, Patel et al., (2012) did not

investigate the protein levels of ChAT in the PPT and the neuronal populations it
innervates to indirectly quantify the extent of Cre-mediated recombination. Our Western
blot analysis showed that the thalamus, the primary output centre of the PPT, had an
almost 100% decrease in VAChT levels. As projections from the PPT are the major
source of ACh to the thalamus (Kotegal et al., 2012), these results strongly indicate that
most cholinergic projections from the PPT to the thalamus did not have VAChT in their
nerve terminals. While the Western blot analysis supports that the decrease in VAChT
expression is restricted to the rostral brain, the immunohistological analysis indicates that
these mice have only a partial decrease in VAChT expression, and subsequently
cholinergic signaling, in the PPT.

6.1.1

Locomotion and gait

VAChTEn1-Cre-flox/flox mice showed normal spontaneous locomotor activity in an open
field, no muscular weakness in the grip strength or wire hang test, and their performance
in the rotarod task was not significantly different from controls, indicating that these
mutants were physically fit. These data indicate that the release of ACh from the
cholinergic neurons of the PPT is not required for spontaneous locomotor activity or
neuromuscular functioning.
Previous studies using lesions of the PPT to examine the effects of PPT signaling on
spontaneous locomotion have found similar results. Steiniger and Kretschmer (2004)
found that bilateral lesions of the PPT had no effect on spontaneous motor behaviour in
rats. Hernandez-Chan et al. (2011) also found that bilateral lesions of the PPT with
quinolinic acid failed to produce changes in motor activity. However, these lesions
eliminated not only cholinergic, but also glutamatergic and GABAergic neurons from the
PPT. Different from our results, Patel and colleagues (2012) who evaluated locomotor
activity in conditional ChAT knockout mice using the En1-Cre driver, suggested that the
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En1Cre; ChATflox/flox mice were hypoactive. Like the VAChTEn1-Cre-flox/flox mice, the En1Cre;
ChATflox/flox mice showed loss of cholinergic activity in the PPT (Patel et al., 2012). One
possible explanation for the hypolocomotion phenotype observed in En1Cre;
ChATflox/floxmice is the different background. Although Patel et al. (2012) did not report
the background of the mice they used in their studies, it is possible that they were mainly
129S1/SvImJ, as the En1Cre mice (Jax stock# 007916) are provided from Jax Laboratories
in this background. Mice on a different 129 background, including 129S1/SvImJ,
129S6/SvEvTac, and 129X1/SvJ, have been reported to be hypoactive when compared to
mice in C57Bl/6 background (Thomsen et al., 2011). For our studies, we initially
backcrossed the En1Cre mice twice to a C57Bl/6 background before we crossed them to
the VAChTflox/flox mice. Thus, in the VAChTEn1-Cre-flox/flox mice the C57Bl/6 background
predominates over the 129S1. Additionally, our experiments with the VAChTEn1-Creflox/flox

mice indicate that these mice travel 300 m in the first 10 minutes of the

spontaneous locomotion in an open field test, which is the same distance travelled for the
En1Cre; ChATflox/flox in the first 10 minutes of the open field test that Patel et al. (2012)
performed. It is possible that the reason the En1Cre; ChATflox/flox mice are hypoactive
compared to controls is that the authors used an unknown combination of Nkx2.1Cre,
En1Cre and ChATflox/+ mice as controls. It has been shown in our lab that Nkx2.1Cre mice
have greater spontaneous locomotor activity than the En1Cre mice (unpublished data).
Our finding that cholinergic tone from the PPT does not influence neuromuscular
functioning, as measured by the rotarod task, is supported by a study by Machold (2013).
Machold (2013) tested En1Cre; ChATflox/flox mice on an accelerating rotarod , and found no
significant difference btween these mice and controls in the latency to fall off the rotarod
over the two consecutive days of training. As these En1Cre; ChATflox/flox mice also have a
deficit in cholinergic signaling from the PPT, these data support our finding that ACh
release from the PPT is not involved in motor control.
The PPT is thought to have a role in the initiation and maintenance of gait (GarciaRill 1991; Winn 2006; Karachi et al., 2010) and lesions of the PPT cause abnormalities in
gait (Karachi et al., 2010). Importantly, PD and PSP are accompanied by approximately
40% cholinergic neuron loss in the PPN (Hirsch et al., 1987, Zweig et al., 1989), and
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different studies have suggested that a loss of cholinergic signaling from the PPN causes
physical abnormalities in PD and PSP patients. For instance, PET studies of PD patients
with several postural instability leading to falls had significantly less cholinergic
innervation in the thalamus from the PPN than non-fallers (Bohnen et al., 2009; 2012).
PSP patients have an even greater loss of thalamic cholinergic activity in combination
with more severe balance impairments and falls than PD patients (Hirsch et al., 1987;
Wenning et al, 1999). The motor symptoms of PD (gait freezing and postural instability)
remain unaffected by dopamine replacement therapy with levodopa suggesting that these
symptoms are not a result of the loss of dopaminergic signaling in these individuals
(Pahapill and Lozano, 2000; Fernandez 2012). On the other hand, the anticholinesterase
inhibitor donepezil reduced the number of falls in frequently falling PD patients (Chung
et al., 2010). We observed deficits on gait parameters in VAChTEn1-Cre-flox/flox mice using
the CatWalk gait analysis system. In both young mice (3-6 months of age) and old mice
(12 month of age), the animals walked with a decreased paw area. This is indicative of a
slight postural instability as a decreased paw area could suggest that the VAChTEn1-Creflox/flox

mice are walking on the sides of their paws or on their toes. Thus, our data give

further support to the hypothesis that cholinergic signaling from the PPT is important for
modulation of gait.

6.2 Psychiatric-like phenotypes
The cholinergic system has long been thought to play an important role in the
etiology of depression (Janowsky 1972).

This hypothesis has been supported by a

number of animal and clinical studies. For instance, Mineur et al. (2013) showed that
physostigmine-injected mice spent significantly more time immobile in the tail
suspension test than controls, suggesting that the increased cholinergic tone in the brain
resulted in this depressive-like behaviour. Physostigmine, is a AChE inhibitor used to
increase cholinergic tone in the brain. In contrast, administration of nAChR antagonists
(such as mecamylamine) to mice to cause a global decrease in cholinergic tone in the
brain, results in an antidepressive-like phenotype in both the forced swim test and the tail
suspension test (Andreasen 2008). Additionally, knockout mice lacking

2 subunit-

containing nAChRs spend less time immobile in the tail suspension test and forced
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swimming test, indicating that decreased cholinergic signaling via nAChRs may
contribute to an antidepressive-like phenotype in mice (Caldarone et al., 2004). In all, it is
clear that brain cholinergic tone is involved in depressive-like behaviour, but the
mechanisms and specific cholinergic nuclei involved are not known. Our results suggest
that ACh released from the PPT, at least in part, might be mediating the effects of
depression. In both the forced swim test and the tail suspension test, the VAChTEn1-Creflox/flox

mice spent significantly less time immobile than the VAChTflox/flox control mice.

This decrease in immobility time is indicative of an antidepressive-like phenotype in
these animals. This suggests that the decreased cholinergic signaling from the PPT is
responsible for the antidepression-like behaviour in these animals.
Interestingly, previous PPT lesion studies have revealed a surprising connection
between the PPT and another psychiatric-like behaviour: anxiety. Several studies have
reported increased anxiety-like behaviour in rodents after PPT lesions. Anxiety in
animals is evaluated by comparing their avoidance behaviour in the presence of putative
anxiogenic stimuli (for example walled vs. open arms and dark vs. light compartments)
(Dere et al., 2002). NMDA-induced PPT lesions, as well as bilateral electrolytic lesions
of the PPT have produced increased anxiety-like behaviours in the elevated plus maze
test (Leri and Franklin 1998; Podhorna and Franklin 1999). In contrast, Homs-Ormo et al
(2002) tested bilateral electrolytic lesions of the PPT on the behaviour of rats in the
elevated plus maze and found that there was no difference between the lesioned animals
and the sham animals during this task. The contrasting results obtained in these lesion
studies are likely due to the differing populations of neurons targeted by the lesion, and to
date, no studies have specifically isolated the role of ACh release from the PPT on
murine anxiety. In this study, we observed that cholinergic signaling from the PPT do not
seem to have strong influence in the regulation of anxiety as deletion of VAChT in the
PPT led to deficits in the light/dark place preference test, but did not lead to deficits in the
elevated plus maze or the time in spent in the centre of the open field arena.
In the literature, the marble-burying assay has been used to evaluate either anxietylike and/or repetitive-like behaviours (Thomas et al., 2009). Interpretation of this test can
consider the burying behaviour as an anxiety-like behaviour in response to a novel
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stimuli, or as a obsessive/compulsive-like behaviour (Thomas et al., 2009). If viewed
through through the anxiety-like behavior paradigm, these data suggest that the decrease
in cholinergic tone from the PPT results in decreased anxiety-like behaviour in this test.
While this result is in contrast to the results obtained in other measures of anxiety-like
behaviour in this study, it has been shown that antidepressants decrease marble burying
behaviour (Li et al., 2006), so its possible that this phenotype is an artifact of the
antidepressive-like behaviour seen in the VAChTEn1-Cre-flox/flox animals. Thomas et al.
(2009) propose that marble burying reflects a perseverative behaviour more than noveltyinduced anxiety. If considered in this manner, the loss of cholinergic tone in the PPT
results in decreased repetitive behaviours. In terms of the role of cholinergic signaling
from the PPT in compulsivity or perseverative behaviours, little is known. The present
finding that mice lacking cholinergic signaling from the PPT have a decreased
compulsive-like phenotype in the marble burying task is novel. Ahmari and collegues
(2013) used optogenetics in mice to stimulate the ventral striatum and hyperactivate the
cortico-striatal-thalamic-cortico (CSTC) circuit, and found that this resulted in a
persistent increase in grooming, which is a mouse behaviour related to OCD. The PPT
has direct influence on this circuitry (Winn 1998), so it is possible that the loss of
cholinergic input to the CSTC results in the decreased compulsive-like behaviours seen in
the VAChTEn1-Cre-flox/flox animals during the marble burying task. Additionally, a feature of
the 5-choice serial reaction time task is that it also provides a means of evaluating
perseverative behaviour in the animals. During the probe trial with a 0.8 s stimulus, the
VAChTEn1-Cre-flox/flox mice show a strong trend towards a decreased perseverative response
compared to controls. However, the 5-CSRTT does not adequately measure attention and
compulsivity simultaneously. This trend requires further investigation as changing the
parameters of the 5-CSRTT and increasing the number of mice used in the study may
reveal a decreased-compulsivity phenotype in these animals that would support the
results seen in the marble burying task.
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6.3 Attention, sleep and cognition
The PPT has very strong reciprocal connections to the corticostriatal circuits, so it is
often thought to be involved in many higher cognitive functions such as learning,
memory and attention (Mena-Segovia et al., 2004).
It has been shown that the PPT has an important role in the regulation of working
memory (Keating and Winn 2002; Taylor et al. 2004). Taylor et al. (2004) used the
delayed spatial win-shift (DSWS) radial maze task to evaluate working memory and
found that rats with bilateral electrolytic PPT lesions performed significantly worse than
the sham lesion rats, making about four errors per test compared to the average rate of
less than one error per test for the sham operated rats. VAChTEn1-Cre-flox/flox mice did not
show any differences in performance from the littermate controls when we evaluated
working memory using the spontaneous alternations Y-Maze, suggesting that the PPT
cholinergic tone is not important for working memory function. Taken together, these
results indicate that the working memory deficits observed in studies using PPT lesions
(Keating and Winn 2002; Taylor et al. 2004) are due to the loss of glutamatergic and
GABAergic signaling from the PPT. Alternatively, since the VAChT ablation is not in
100% of PPT cholinergic neurons, there is the possibility that some of the specific
cholinergic neurons involved in working memory have not been affected by Cremediated recombination and thus working memory is not affected in these animals.
When spatial learning and memory was evaluated using the spatial version of the
Morris water maze (MWM), VAChTEn1-Cre-flox/flox mice showed a strong impairment in
spatial navigation during the spatial version of the MWM, with a greater latency to find
the platform than controls during the acquisition phase, and no preference for the target
zone during the probe trial. Stackman and Lora et al. (2012) showed that inactivation of
the anterior thalamic nuclei with muscimol resulted in deficits in the performance of mice
in the spatial MWM. The PPT has direct cholinergic afferents to the ATN (Gonzalo-Ruiz
et al., 1995) and with the cholinergic signaling from the PPT to the thalamus almost
abolished in the VAChTEn1-Cre-flox/flox mice, its possible that the cholinergic input to the
thalamus from the PPT is necessary for spatial memory. Another possible interpretation
of deficits of the VAChTEn1-Cre-flox/flox mice in the spatial MWM is that the cholinergic
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signaling from the PPT is important for learning. The DSWS maze used by Taylor and
colleagues (2004) was used to evaluate working memory, but this test is also very
challenging to an animal’s ability to use spatial cues. In the first stage of training in the
DSWS maze, all four arms of the maze are open and there is no reward, there is no
impairment of the lesioned animals’ performance (Taylor et al., 2004). This apparatus is
similar to the Y-maze used in this study, where there are three open arms of the maze for
the animal to explore. It is only when the difficulty of the DSWS task is increased (by
changing the arms of the maze that contain the reward) that the lesioned animals present
impairments (Taylor et al., 2004). This suggests that it may not be working memory that
is affected by the PPT lesion, but their ability to learn. This explanation accounts for a
normal working memory in the Y-maze (where no training is involved) but impaired
learning of the location of the escape platform in the MWM in the VAChTEn1-Cre-flox/flox
mice.
To explore goal-directed learning in the VAChTEn1-Cre-flox/flox mice further, the goaldirected version of the Morris water maze was used. This version of the Morris water
maze uses a similar paradigm to the DSWS task where animals must swim to a platform
indicated by a cue in 8 different positions to receive the reward of being removed from
the tank of water. On the testing day, the combination of the animal’s starting location
and the location of the cued-platform was one that was not used during the acquisition
phase. Here, we saw significant deficits in goal-directed learning in the cued version of
the MWM. Mice lacking cholinergic tone in the PPT showed significantly greater
latencies to find the platform during the acquisition phase than the control mice, and an
even greater deficit during the testing phase. This deficit in goal-directed behaviour was
further emphasized by the VAChTEn1-Cre-flox/flox mouse their path traces, which indicate
that the mice often swam in thigmotaxis, which is correlated with stress and anxiety in
animals (Graziano et al., 2003). This swimming strategy was also observed in the spatial
version of the MWM. Since the escape platform in this test is visible to the mice by a
very obvious cue, the mice do not have to use their spatial learning and memory skills to
locate it in the tank. The inability of the VAChTEn1-Cre-flox/flox mice to learn the location of
the platform in both the spatial and cued versions of the MWM strongly suggests that the
release of ACh from the PPT is critical for learning.
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Finally, attention was evaluated in these mice using the 5-CSRTT. Our data
demonstrates that the VAChTEn1-Cre-floxflox mice were unhindered in their ability to learn
the conditions of each pre-training phase and subsequently required the same number of
sessions to meet the criteria to pass the pre-training phase as the control mice did. While
the VAChTEn1-Cre-flox/flox mice are not significantly different from controls in their ability
to learn the requirements of the 5-CSRTT training phases, there is a trend that the
VAChTEn1-Cre-floxflox mice required more training days to meet the criteria to pass the 4s
stimulus training phase. Increasing the number of mice performing the 5-CSRTT may
reveal a learning deficit at this training phase. During the 5-CSRTT probe trial, the mice
did not demonstrate any attentional deficits as their accuracy and number of omissions
were not significantly different from controls. Inglis et al (2000) reported global
attentional deficits in rats with bilateral PPT lesions in the 5-CSRTT, which were
alleviated by decreasing the attentional demands of the test. As our results suggest that
cholinergic efferents from the PPT do not seem to be required for normal attention
processes, it is possible that the glutamatergic and GABAergic neurons in the PPT that
were lesioned in addition to cholinergic neurons were responsible for the deficits
observed by Inglis and colleagues. It is also possible that a sub-population of cholinergic
efferents spared in VAChTEn1-Cre-flox/flox could be responsible for the intact attentional
performance.

6.4 Limitations
The primary limitation of this study is that these animals are born with the decreased
cholinergic tone in the PPT and as a result they may develop compensatory mechanisms
in the brain during development. The engrailed (En) homeobox 1 transcription factor is
crucial for the formation of the midbrain [mesencephalon (mes)] and anterior hindbrain
[rhombomere (r1)] during embryonic development (Sgaier et al., 2007). En1 acts at the
mid-hindbrain junction between embryonic day 8.5 and 13, so Cre-mediated
recombination was occurring during the initial formation of this brain structure. In this
study, it is not possible to determine if the observed altered behaviours are due singularly
to the loss of cholinergic signaling from the PPT, or from the combination of
compensatory changes that have occurred since birth.
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6.5 Future directions
To further expand on the results from this study, it would be of value to continue to
characterize the compulsive-like behaviours seen in the VAChTEn1-Cre-flox/flox mice. By
increasing the number of mice used in the 5-CSRTT and by changing the parameters of
the test to test for perseverative behaviours, it would confirm if the trend towards a
decreased perseverative behaviour is in fact a phenotype for the VAChTEn1-Cre-flox/flox
mice that reflects the decreased compulsive-like behaviours seen in these animals in the
marble burying task.
Additionally, it is necessary to account for any compensatory mechanisms that
may have occurred in the VAChTEn1-Cre-flox/flox mice as the decrease in cholinergic tone
was present since early embryonic development. For future studies, a Cre recombinase
virus will be injected into the PPT of adult VAChTflox/flox mice and the behavioural tests
will be repeated in order to identify any effects from this potential compensation.
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Chapter 4

7

Conclusions
The present data provide evidence for the role of cholinergic signaling from the

pedunculopontine tegmental nucleus as the mice used in this study provide a novel means
of selectively reducing ACh release from the PPT without damaging the cholinergic
neurons or altering their potential release of other neurotransmitters/modulators. The
present findings from this study suggest that ACh signaling from the PPT is important for
the mediation of depressive-like symptoms and learning and memory, and to a lesser
extent, gait, anxiety-like symptoms, sleep and perseverative-like behaviours. These data
contribute to our current understanding of depression, Parkinson’s disease and
progressive supranuclear palsy. While the idea that dysregulation of the cholinergic
system may contribute to the etiology of major depressive disorder is not novel, to date,
no specific cholinergic nuclei have been implicated. Here, we present data that implicates
cholinergic signaling from the PPT, at least in part, in depressive symptoms. As such,
pharmacological agents that limit ACh signaling from the PPT may have the potential to
ameliorate some of the symptoms of major depressive disorder, and thus lead to the
development of novel antidepressant medications.
Additionally, these data emphasize the role of the PPT in the pathophysiology of
PD and PSP. Some of the symptoms of these neurodegenerative diseases, such as gait
abnormalities, postural instability and falls are not improved by traditional DA treatment
(Nandi et al., 2012). Our data suggest that it is possible that PPT degeneration is also
responsible for some cognitive impairments of PD. For instance, motor symptoms of PD
are often preceded by sleep disturbances (Takakusaki et al., 2011), which may be due to
altereded PPT cholinergic signaling and subsequent alterations in sleep-wake cycles, as
seen in the VAChTEn1-Cre-flox/flox mice.

PD patients also often experience dementia

(Bohnen et al., 2011), which may be due to PPT degeneration, as the data from this study
suggest that intact PPT ACh release is necessary for learning and memory. The findings
from this study further support the role of decreased cholinergic signaling from the PPT
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in the symptoms of PD, and indicate the PPT as a potential target for deep brain
stimulation to treat some PD patients.
As the decrease in cholinergic tone was present in VAChTEn1-Cre-flox/flox since early
development it not possible to rule out the possibility that the effects observed result from
compensatory changes. For future studies, a Cre recombinase virus will be injected into
the PPT of adult VAChTflox/flox mice.
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